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Whole-organ perfusion decellularization was performed with rat hearts on a modified 
chromatography apparatus.  Analysis of the flow properties and effluent material over time 
provided insights into the decellularization process, and allowed non-destructive testing of 
perfused cardiac tissue.  Decellularized matrices were stored for up to 1 year at -80°C and then 
conditioned to remove residual detergent and cryoprotectant.  Tissue was reseeded with canine 
blood outgrowth endothelial cells (BOECs) and cultured in an autoclavable closed-circuit 
bubble-free reactor.  The entire process was considered in the context of eventual scale-up in 
equipment design, the use of disposable components, and extracellular matrix (ECM) product 
storage. 
 
Tissue patch substrates for cell growth were studied for cytotoxic effects towards process 
development.  Decellularization protocols were compared. Extracellular matrix derived coatings 
and gels were investigated as process assays and potential cell delivery vehicles.  Peracetic acid 
and UV disinfection were tested.  Micronized ECM carriers were developed for scalable culture, 
with considerations to carrier morphology, cell attachment, and egress.  Micronized ECM 
carriers were tested with a novel in vitro assay to simulate the support of adherent cells for gene-
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Chapter 1 – Introduction 
 
Hemophilia A is a hereditary clotting disorder caused by a deficiency of the clotting factor VIII 
(FVIII) protein. Symptoms of the disease include painful and recurrent bleeding of the joints, 
while treatment includes costly (~$140 000 US per year) replacement of FVIII (Feldman, Pai et 
al. 2006).  Hemophilia A is one of the most extensively studied disease in gene therapy, owing in 
part to the quantitative clotting assays, and estimated clinical significance at even low (2-3% 
wild type) protein expression (Murphy and High 2008). 
 
Promising results have been achieved by delivery of viral vectors designed to deliver functional 
copies of the FVIII-coding gene to patient liver cells.  However, safety concerns including 
adverse immunological reactions, vector-mediated cytotoxicity, germ-line transmission, and 
oncogenesis remain.  An ex vivo approach may reduce these risks by delivering patient cells that 
have been transfected, expanded, and tested outside of the body prior to re-implantation (Lin, 
Chang et al. 2002; Matsui, Shibata et al. 2007). 
 
Blood outgrowth endothelial cells (BOECs) have been employed as a target cell for ex vivo gene 
therapy of the FVIII-coding gene (Lin, Chang et al. 2002).  BOECs can be reproducibly 
produced from human peripheral blood, tolerate growth from low density following selection, 
and have high proliferative potential (Lin, Weisdorf et al. 2000).  These advantages have 
facilitated the production of transfected therapeutic BOECs, however when injected back into 




One cause of early losses in transplanted cells may be anoikis, a programmed cell death 
associated with lack of attachment in adherent cells (Frisch and Screaton 2001).  Delivering cells 
with a surface carrier has improved survival of transplanted chromaffin cells in the rat striatum 
(Saporta, Borlongan et al. 1997), hepatocytes in the rat peritoneum (Demetriou, Reisner et al. 
1988), and bone mesenchymal stromal cells in subcutaneous implantation (Yang, Rossi et al. 
2007).  Developing a tissue engineering approach including a biocompatible scaffold or carrier 
may promote long-term survival of delivered cells and extend in vivo production of FVIII. 
 
Decellularization is the process of removing cells and cellular debris from a tissue to isolate the 
extracellular matrix (ECM) of the tissue (Badylak, Taylor et al.).  In vivo, the ECM supports cells 
through structural support and complex signaling integration (Hynes 2009).  Transplant 
applications of decellularized tissue include recellularization of ECM towards the production of 
patient-specific functional adult tissue (Ott, Matthiesen et al. 2008; Uygun, Soto-Gutierrez et al. 
2009; Ott, Clippinger et al. 2010).   The cell-supportive properties of tissue-derived ECM may 
facilitate gene-modified cell therapy, and are discussed in more detail in Chapter 2.  The 
development and processing of ECM-based constructs for gene-modified cell therapy is the 
focus of the work presented in this thesis. 
 
The support of implanted endothelial cells may not require the complex co-cultures and large-
scale architecture of the replacement tissues.  Consequently, a variety of source tissues and 
configurations of ECM products may be suitable for improving adherent cell delivery and 
survival and are explored in this work.  In addition to whole-organ ECM scaffolds, micronized 
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ECM developed for wound repair and surgical augmentation (Sclafani, Romo et al. 2000; Zhang, 
Deng et al. 2009) were investigated.  Tissue-specific ECM gels used to promote cell phenotype 
in culture (Zhang, He et al. 2009) were also studied.  In this work, source tissue was collected 




Chapter 2 – Literature Review 
 
2.1 Properties of Extracellular Matrix 
 
Tissue-derived extracellular matrix (ECM) is a model material for the development of near-
native tissue constructs; it resembles native tissue in composition (Akhyari, Kamiya et al. 2008), 
mechanical properties (Gratzer, Harrison et al. 2006), and vasculature structure (Ott, Matthiesen 
et al. 2008).  In vivo, native ECM helps regulate cellular differentiation, proliferation, and 
migration.  Mesenchymal stem cell differentiation is sensitive to the mechanical stiffness of the 
collagen matrix used for culture (Engler, Sen et al. 2006).  Growth factors such as epidermal 
growth factor and insulin-like growth factor-1 are immobilized in the ECM by 
glycosaminoglycans (GAGs), and impact cellular migration (Stefonek-Puccinelli and Masters 
2008).  Cryptic sites within ECM facilitate angiogenesis (Xu, Rodriguez et al. 2001), and ECM 
degradation products attract progenitor cells (Beattie, Gilbert et al. 2009). 
 
The goal of decellularization is to produce an ECM isolate free of cells and cellular remnants 
such as DNA, membrane fragments, and cytosolic materials.  Protocols to extract 
morphologically preserved and chemically pure extracellular matrix have been available for 
more than thirty years (Meezan, Hjelle et al. 1975) and vary extensively.  Basic methods of 
decellularization include mechanical, freeze/thaw, alkaline or acid, enzymatic, detergent, and 
solvent treatments, and have been extensively reviewed (Gilbert, Sellaro et al. 2006).  The 
isolation of ECM is both a chemical and a transport problem:  the cellular components must be 
brought into solution in a manner that is minimally disruptive to the surrounding matrix; and 
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these components must pass through any interstitial matrix, compartments, and membranes to the 
exterior of the tissue.  In practice, convective decellularization by perfusion is more effective in 
removing cellular materials such as phospholipids than batch decellularization with agitation, 
regardless of the specific solubilization treatment (Montoya and McFetridge 2009).  In these 
systems, increased pressure also significantly increases lipid removal, highlighting the 




2.2.1 Phospholipid Removal 
 
The process of phospholipid bilayer solubilization can be described by the three-stage hypothesis 
(Helenius and Simons 1975):  First, detergent monomers are incorporated into the lipid bilayer.  
The bilayer then becomes saturated with detergent, reaching equilibrium with newly-formed 
mixed micelles that are saturated with phospholipid.  In the final stage, membrane components 
are fully solubilized within mixed-micelles that decrease in size as detergent concentration rises, 
approaching the behaviour of pure detergent micelles.  For decellularization, the soluble, 
phospholipid-bearing mixed-micelles must then be removed from the system. 
 
A geometric interpretation of the three-stage hypothesis can be provided by wedge theory 
(Haydon and Taylor 1963).  This theory proposes that the two hydrocarbon chains of a 
phospholipid are similar enough in size to the polar head to prevent the formation of soluble 
micelles, leaving a continuous bilayer as the most favoured structure.  However, molecules with 
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relatively large polar groups and narrow hydrocarbon structures, such as detergents, are 
sufficiently wedge-shaped to form micelles and can cause the disruption of the lipid bilayer upon 
their insertion. 
 
The three-stage hypothesis only describes the solubilization of a chemically pure phospholipid 
bilayer. The behaviour of cell membranes can be more closely modeled by considering a 
membrane composed of two distinct phospholipids interacting with a detergent in aqueous 
solution and forming four phases: liquid-ordered membranes, liquid-disordered membranes, 
micelles, and dissolved detergent monomers (Keller, Tsamaloukas et al. 2005).  An advantage of 
this model is its consistency with the presence or formation of detergent-resistant membrane 
fragments (Yu, Fischman et al. 1973), that survive mild detergent treatments. 
 
2.2.2 Protein Solubilization 
 
Detergent solubilization of proteins also begins with detergent monomers in solution (Helenius 
and Simons 1975).  These molecules bind to discrete sites on the protein, which can vary in their 
affinity for detergent molecules.  Binding can be cooperative and accompanied with a 
conformational change of the protein that exposes previously buried lipophilic groups, especially 
for strong detergents.  For mild detergents, it may be possible that not all detergent molecules 
bind directly with the protein, with some molecules binding cooperatively to form a micelle-like 
region on the surface of the protein.  At higher detergent concentrations, proteins may associate 




2.2.3 Detergent Strength 
 
Detergents vary in their strength to bind and denature proteins. Detergents are commonly 
classified by their hydrophilic character as non-ionic, zwitterionic, anionic, or cationic.  Another 
important distinction can be made between the hydrophobic groups composed of flexible alkyl 
chains or the rigid and bulky steroid moiety of bile salts.  The relative size and strength of the 
hydrophilic and lipophilic groups can be used to calculate a hydrophilic-lipophilic balance 
(HLB) and roughly characterize the strength of a detergent.  Assigned values have ranged from 1 
to 40, with higher numbers corresponding to increasing hydrophilic character (Griffin 1949).  
Detergents with HLBs between 12 and 16 are considered relatively non-denaturing, and values 
above 20 are more likely to denature protein.  (Rosenberg 2004). Sodium dodeceyl sulfate, for 
instance, has an HLB of 40 and increases the crimp amplitude and periodicity of collagen, and 
increase the susceptibility of collagen to trypsin in porcine ligament, suggesting matrix 
denaturation during decellularization (Gratzer, Harrison et al. 2006). 
 
However, HLB values alone cannot predict the denaturing behaviour of a decellularization 
solution.  Detergent free monomer concentration and negative synergism between detergents also 
determine binding and extent of denaturation (Miyazawa, Ogawa et al. 1984).  Detergent-protein 
binding is also influenced by temperature, pH, ionic strength, and other environmental effects 
(Otzen 2002).  Additionally, not all proteins are equally susceptible to denaturation by a given 




An ideal decellularization process is optimized for maximum solubilization of cellular 
components with minimum denaturation of native ECM proteins.  This also requires a 
prioritization of ECM components for a given application.  To improve the quality of ECM, 
additional processing may required.   Examples could include the replacement of any desirable 
ECM proteins lost in extraction, repair by fibroblast culture, or partial refolding with chaperone 
proteins. 
 
2.2.4 Detergent Properties 
 
Physical parameters of candidate detergents are presented in Table 1.  SDS and Triton X-100 
occur frequently in literature and are some of the best characterized detergents.  Triton X-100 has 
been found insufficient for cardiac decellularization (Ott, Matthiesen et al. 2008).  N-Lauroyl 
Sarcosinate has been used as a less-denaturing alternative to SDS in cardiovascular applications 
(Ketchedjian, Jones et al. 2005).  Bile salts are also commonly employed, often used in 
combination with Triton X-100 (Samouillan, Lamure et al. 2000; Spina, Ortolani et al. 2003).  
Centrimonium bromide (CTAB) is less often employed in decellularization, but is often used in 










Triton X-100™ Non-ionic  13.41 0.252 










Cationic4  21.44 1(40)5  62,000(40)5 
N-Lauroyl 
Sarcosinate 
Anionic5  29.85 14.6(40)3  600(40)3 
Sodium Dodecyl 
Sulfate (SDS) 
Anionic1 40.01 1.2 – 7.12 17,800 – 29,1002 
Table 2.1 Properties of Detergents Tested for Decellularization.  
 
Hydrophilic-lipophilic balance values indicate the relative strength of the detergent.  The 
critical micellar concentrations are the concentration at which given detergent molecules 
form micellar structures. CMC values correspond to 20-25°C.  Triton X-100™ is a weak 
detergent that forms large micelles at low concentration, compared to SDS, which is 
stronger, and forms smaller micelles at higher concentrations.  (1McCutcheon's Detergents 
& Emulsifiers, 2009; 2le Maire, Champeil, et al. 2000; 3Sigma Aldrich, 2009; 4Retter, Koch, 
et al. 1999; 5DeWolf Chemical, 2000) 
 
 
2.2.5 Detergent Removal 
 
Following decellularization, significant amounts of detergent may remain in the matrix.  
Reduced peptides in the presence of SDS at 0.8mM or greater will form complexes of about 1.4g 
SDS per gram protein (Reynolds and Tanford 1970). SDS can also form complexes with 
membrane glycoproteins containing as much as 5-7g SDS per gram protein, likely due to 




The critical micelle concentration (CMC), where monomers in solution begin to form micelles is 
low for the most commonly used detergents in decellularization, typically only a few millimolar.  
Detergent-protein binding also occurs at free monomer concentrations well below the CMC 
(Miyazawa, Ogawa et al. 1984), permitting a limited concentration gradient for detergent 
removal during tissue rinsing. 
 
Radiolabelled detergent molecules have been used to validate the removal of N-lauroyl 
sarcosinate from a 1cm2 section of sheep heart using a 24-36 hour rinse of sterile water, 
recirculating through hydrophobic adsorbent resin and anion exchange resin beads (Ketchedjian, 
Jones et al. 2005).  A half-hour Triton X-100 wash, followed by a 124 hour PBS wash has been 
used to remove residual SDS from a perfusion-decellularized rat heart (Ott, Matthiesen et al. 
2008).  This procedure presumably took advantage of the negative synergism between detergents 
resulting from competing formation of mixed detergent micelles (Miyazawa, Ogawa et al. 1984).  
SDS removal has also been performed with a pH 9 buffer and, alternatively, a 75% ethanol 
solution in porcine ACL tissue, with residual detergent quantified with methylene blue dye-
binding assay (Gratzer, Harrison et al. 2006).  
 
2.2.6 Detergent Transport 
 
Detergent, nuclear material, soluble cellular protein, and detergent-protein complexes must all 
travel through tissue interstitial matrix and endothelial basement membranes during the 
decellularization of whole organs or tissue sections large enough to support a cell therapy 
implant.  A better understanding of these transport phenomena will aid in the preparation of 
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extracellular matrix for a target application.  For example, convective flow decellularization was 
found to be more efficient than rotary agitation decellularization, with low pressures associated 
with most efficient protein removal, and high pressures corresponding to more efficient 
phospholipid extraction in a solvent mixture (Montoya and McFetridge 2009). 
 
Flow through the intersitium has been previously reviewed by other groups (Levick 1987), and 
some useful introductory information will be repeated here.  The intersitium fills the intercellular 
spaces of an adult and allows 2-4 L of plasma ultrafiltrate to flow into the lymphatic system per 
day.  It is composed of coarse fixed elements, such as collagen fibrils and a fine meshwork of 
glycosaminoglycans (GAGs) surrounding a core proteoglycan protein immobilized onto the 
larger network.  These substances are hydrated, expanding their effective size.  Observed 
hydraulic conductivities for tissues of low and high cell density have shown the matrix to 
dominate flow resistance in whole tissues.  Mean hydraulic radii have been calculated for the 
interstitium considering collagen fibrils, proteoglycans, and GAGs as randomly oriented 
cylinders.  Several mean hydraulic radii have been calculated, ranging from 3 to 31nm, 
depending on tissue.  It was found that GAGs, collagen, and proteoglycans together provide 
resistance greater than that of their individual contributions.  This is consistent with experiments 
in tumour models that suggest proteoglycans and GAGs must be fixed to the collagen network to 
exhibit their full transport-limiting effect (Netti, Berk et al. 2000).  Conductivity experiments on 
a basement membrane formed from Matrigel™ have yielded a mean hydraulic radius of 0.6 to 




Experiments with dynamic light scattering have been performed to study the interaction of Triton 
X-100™ with phosphatidylcholine liposomes (Lopez, de la Maza et al. 1998).  The detergent 
monomers were found to have a hydraulic radius of 5.0nm in a system of TRIS buffer with 
liposomes of 100nm radius.  Mixed micelles, saturated with detergent were found to have a 
hydraulic radius of 5.9nm.  As the detergent concentration increased, larger mixed vesicles and 
mixed micelles appeared, while pure liposomes decreased in size.  Eventually, only mixed 
micelles of 8.5nm radius persisted, decreasing to 5.0nm with even higher detergent 
concentration. 
 
A similar experiment was subsequently performed with SDS (Lopez, Cocera et al. 1999).  The 
liposomes initially decreased from a radius of 95 to 85nm as SDS monomers inserted 
themselves.  With increasing detergent, mixed micelles began to form with a radius of roughly 
3nm, coupled with a relaxation of vesicles up to a radius of 110nm.  As SDS concentration 
increased further, only mixed micelles persisted with a radius of 2.6nm. 
 
When bile salts insert themselves into vesicle membranes, transient holes lined with the 
detergent appear, through which some vesicle contents escape (Schubert and Schmidt 1988).  As 
bile salt concentration increases to approximately a third that of the lipid, the membrane holes 
begin to connect, creating islands that leave the membrane.  Experiments with cholate and 
phospholipid have shown that after the detachment of small membrane patches, cylindrical 
vesicles form from the cholate-lined edges of the bilayer sheet (Walter, Vinson et al. 1991).  
These rods have a radius of 2.7nm and a length that decreases with increasing bile salt to 16nm.  
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As cholate concentration increases further, the rods are reduced to spheroidal mixed micelles 
with a hydrodynamic radius of 2-3 nm. 
 
The relative sizes of soluble and detergent-solubilized protein complexes should be considered 
when determining source tissue and protocols to isolate ECM for a target application.  Muscle 
tissue contains large contractile proteins and protein subunits, such as titin and heavy-chain 
myosin, which may be difficult to remove without damage to the basement membrane and 
interstitial matrix.  Mild detergents, such as Triton X-100 and deoxycholate, are unable to 
dissociate most protein complexes into their subunits, instead solubilizing complete quaternary 
structures (Helenius and Simons 1975).  Proteins solubilized in non-ionic detergent can also form 








3.1.1 Tissue Preparation 
 
All animal-related procedures were approved by the University of Waterloo Animal Care 
Committee.  Adult Sprague Dawley rats (480-580g; n = 8) were group housed 4 per cage at 
constant air temperature (20-21°C) and humidity (approx. 50%) in a 12:12-hr reverse light:dark 
cycle facility.  Rats had free access to water and standard 22/5 Rodent Diet (W) lab chow 
(Harlan, Indianapolis IN).  On the day of the experiment, body mass was recorded and rats were 
anesthetized with sodium pentobarbital injection (60 mg/kg intraperitoneally; Vetoquinol N-A, 
Lavaltrie, QC, Canada).  The heart was removed, cannulated with a 10 cm section of polyether 
ether ketone (PEEK) tubing (Supelco Analytical, Bellefonte, PA) and tied with 4.0 silk suture.  
The heart was flushed with 2500 U of heparin (Bioshop, Burlington ON, Canada) in phosphate 
buffered saline (PBS) via cannula until the effluent was clear, and then placed in chilled PBS 
prior to decellularization. 
 
3.1.2 Perfusion Decellularization 
 
Cannulated hearts were connected to a modified chromatography system (Figure 3.1A) including 
a peristaltic pump, injection loop, and fraction collector (Amersham Bioscience AB, Uppsala, 
Sweden).  The tissue was placed in a glass enclosure and then perfused at a flow rate of 2 
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mL/min with PBS containing 1% (w/v) sodium dodecyl sulfate (Bio-Rad Laboratories, Hercules, 
CA).  The effluent material was collected in 15 mL fractions that were analyzed with a 
detergent-compatible modified Lowry protein assay (Bio-Rad Laboratories) in a plate 
colorimeter (Molecular Devices, Sunnyvale, CA).  For tracer pulse experiments, a 200 μL 
injection loop was loaded with 10 μM fluorescein isothiocyanate (FITC).  Flow was reduced to 1 
ml/min during pulse injections and effluent was collected dropwise over 2 min.  Effluent was 
assayed in a plate fluorometer (Molecular Devices, Sunnyvale, CA) against a standard curve and 
normalized to total tracer.  Decellularization was considered complete when the heart had a 
uniform translucent appearance, typically after 24 hr perfusion. 
 
 
Figure 3.1 – Decellularization Apparatus and Physical Observations 
 
The decellularization apparatus (A) comprises an injection loop (i), glass enclosure (ii), 
peristaltic pump (iii), fraction collector (iv), and detergent solution (v).  Decellularization 
occurs early in the aortic arch and carotid arteries.  The dense ventricular mass 
decellularized more slowly.  This may be due to mass transport limitations. 
16 
 
3.1.3 Cryostorage and Reconditioning 
 
After decellularization, the cannulated hearts were removed from the perfusion system and 
stored in 10% DMSO in PBS at -80°C for up to 1 yr.  Cannulated tissue was thawed in a 
polypropylene container in a water bath at 37°C, and rinsed thoroughly with deionized (DI) 
water.  The PEEK tubing was connected to the reconditioning system and perfused with 1% (v/v) 
Triton® X-100 (Sigma-Aldrich Canada Ltd., Oakville, ON, Canada) in deionized water for 3.5 
hr at a flowrate of 2 mL/min at room temperature.  The cannulated tissue was then perfused with 
DI water for 1 hr, removed from the apparatus, and then incubated with 6.7 U/mL Benzonase™ 
nuclease (EMD Biosciences, San Diego, CA) in buffer (50 mM Tris-HCL pH 8, 20 mM NaCl, 2 
mM MgCl2) for 3.5 hr at 37°C.  The tissue was then re-mounted on the reconditioning apparatus 
(Figure 3.2) and perfused with a 1.8% (w/v) skim milk powder solution for 1.5 hr followed with 
1 hr rinse of DI water. The tissue was removed from the pumping system and flushed via the 
cannula and soaked with a disinfecting solution (Remlinger, Czajka et al.) of 0.1% (v/v) 
peracetic acid and 4% (v/v) ethanol in DI water for 20 min.  The tissue was then flushed and 
soaked in DI water, media, and fetal bovine serum for 1 hr each, with aseptic handling performed 





Figure 3.2 – Tissue Reconditioning 
 
Tissue was loaded in a second apparatus (A) comprising a peristaltic pump (i), glass 
enclosure (ii), and waste resevoir (iii) to be perfused with protein solution and water rinses 
(iv) to remove residual cryoprotectant, and replace adsorbed detergent.  Tissue is shown 
following perfusion (B).  Nuclease incubation and FBS rinses were also applied to reduce 
cytotoxicity of the culture surface. 
 
 
3.1.4 Cell Maintenance 
 
Canine blood outgrowth endothelial cells (cBOECs) were a generous gift from Dr. David 
Lillicrap, Queen’s University.  Cells were cultured in MCDB-131 (Invitrogen Canada Inc., 
Burlington, ON, Canada) supplemented with an endothelial growth medium-2 Sinqlequot™ 
(Lonza, Walkersville, MD), 2 mM L-Glutamine, and 10% (v/v) fetal bovine serum (Invitrogen 
Canada Inc., Burlington, ON, Canada) .  Cells were cultured in tissue-treated 75 cm2 polystyrene 
flasks (BD, Mississauga, ON, Canada) coated with gelatin from bovine skin, type B (Sigma-
Aldrich Canada Ltd., Oakville, ON, Canada) in a controlled atmosphere at 37°C and 5% CO2.  
Cells were passaged at 90% confluency with 2.5 g/L trypsin with 0.38 g/L EDTA (Invitrogen 




3.1.5 Seeding and Recellularization Culture 
 
Trypsinized cells (2x107) were concentrated and resuspended in 2mL of medium and injected via 
the cannula and directly through the walls of the heart at regular spacing (~5mm) with an 18 
gauge needle.  The tissue was placed in static culture at 37°C with medium for 45 min before 
being loaded into the sterile recellularization culture reactor in a biological safety cabinet (Figure 
3.3).  The reactor included a modified spinner flask in which the tissue was partially submerged 
in 500mL of recirculating media that had been equilibrated at 37°C and 5% CO2.  The closed 
tubing circuit, including vessels, was attached to the peristaltic pump (Cole-Parmer, Vernon 
Hills, IL), placed in an incubator, and connected to a gas line of 5% CO2, with balance oxygen 
(Praxair Canada Inc., Mississauga, ON, Canada).  The media was drawn into the peristaltic pump 
at a rate of 3 mL/min and sent to a gas-exchange vessel containing 25 ft of silicone rubber 
laboratory tubing with 1/8” inner diameter and 1/32” wall thickness (Sigma-Aldrich Canada Ltd., 
Oakville, ON, Canada).  The media was passed through a glass settling chamber before entering 












Figure 3.3 – Recellularization Culture 
 
Conditioned tissue was loaded into a culture apparatus (A) comprising a 95% oxygen, 5% 
carbon dioxide atmosphere (iv) controlled with a needle valve (i) and delivered in a bubble-
free aerator (ii).  Media was circulated with a peristaltic pump (iii) and passed through a 
settling chamber to collect debris and bubbles before entering the semi-submerged culture 





3.1.6 Staining and Imaging 
 
After culture, the tubing circuit and vessels were brought into a biological safety cabinet, and the 
tissue was removed for dissection.  A randomly selected portion of the ventricular mass was 
excised  and incubated at 37°C in media containing 10 μM  CFDA-SE (Invitrogen Canada Inc., 
Burlington, ON, Canada) and 2 μg/mL Hoescht 33342 (ABD Bioquest, Sunnyvale, CA) for 30 
min to stain metabolically active cells, and nucleic acids, respectively.  The tissue section was 
rinsed 3 times with media, then once with PBS.  The sample was fixed in 4% paraformaldehyde 
for 15 min, permeabilized in 0.5% (v/v) Triton-X100™ (Sigma-Aldrich Canada Ltd., Oakville, 
ON, Canada) solution for 20 min, blocked with 5% BSA for 20 min, then rinsed 3 times in PBS 
for 5 min each, stained with AlexaFluor® 546 phalloidin (Invitrogen Canada Inc., Burlington, 
ON, Canada), to stain the cytoskeletal protein F-acticn, washed 3 times for 5 min each in PBS, 
and placed on a coverslip.  Epifluorescent imaging was performed on an inverted fluorescent 
microscope (Axiovert 200; Carl Zeiss MicroImaging GmbH, Berlin, Germany) with a 
monochrome high resolution CCD camera (XCD-SX910/X710; Sony Corporation, Tokyo, 
Japan), followed by sequential fluorescent imaging on a confocal microscope (FV1000; Olympus 










Figure 3.4 – Tissue Sample for Imaging 
 
After 9 days of recellularization culture, tissue was removed from the reactor (A) and 
handled in a biological safety cabinet.  Random tissue was removed (B) and stained in a 
microcentrifuge tube (C).   Tissue was then mounted and the lumen was imaged on an 





Flow models for the decellularizing heart were fitted to reproduce the observed outlet tracer 
pattern using a square pulse of fluorescent tracer at the inlet.  These studies were performed to 
gain a better qualitative understanding of the transport processes of the decellularizing heart.  
Candidate flow models included combinations of ideally mixed tanks and plug-flow tubular 
reactors; tanks in series; and axial dispersion tubular flow.  The models are commonly used to 
diagnose flow behavior in industrial mixing (Blanch and Clark 1996; Fogler 2006) and to study 
material residence in pharmacokinetic models of perfused organs (Roberts, Donaldson et al. 
1988).  Bypassing and dead zones were considered to study leaking and blockage before and 
after decellularization.  These deviations from ideal mixing always lower performance in 
industrial process units (Levenspiel 1999) and may similarly reduce efficiency in 
decellularization processes by allowing solubilized cellular materials to remain in the system, 
and causing detergent to exit the system without  contacting tissue or removing debris.  Models 
were fitted to data at 45 minutes and 15 hours of detergent perfusion from a representative 
decellularization. 
 
Flow models were produced and analyzed using MatLab™ (The MathWorks, Inc., Natick, MA) 













3.2.1 Effluent Protein 
 
To characterize the kinetics of protein removal during decellularization, the protein concentration 
in the effluent from the tissue was measured.  Within six hours of a typical run, protein 
concentration in the effluent was observed to decrease sharply and approach zero in a manner 
that reflected the rate of color loss in the tissue (Figure 3.5).  Total removed material typically 
comprised 130 to 200 mg protein per gram of fresh heart wet weight.  Required decellularization 
time to achieve uniform translucency varied from 6 to 24 hr. 
 
 
Figure 3.5 – Effluent Protein Concentration 
The protein concentration of effluent detergent was assayed for protein content using a 
detergent-compatible modified Lowry assay.  Rate of protein loss was consistent with 
observed rate of colour loss.  Most protein removal occurs in the first hours of perfusion 
decellularization.  Data shown for a typical process run. 
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3.2.2 Perfusion Flow 
 
Non-zero bypass flow was found to reduce goodness-of-fit in all initial models, suggesting the 
absence of leaks.  Bypassing was then excluded from models for model simplification.  Models 
with a maximum of two parameters were evaluated to facilitate physical interpretation and 
improve convergence.  The chosen model comprised two tanks in series with recirculation with 
total perfused volume and recirculation fitted as parameters (Figure 3.6A).  Perfused volume in 
the heart was found to reduce from 0.37 to 0.30 mL, with a reduction in recirculation ratio from 
5.3 to 1.3 between decellularization of 45 min (Figure 3.6B) and 15 hr (Figure 3.6C).  These 
results imply accumulation of cellular debris in the lumen even at late decellularization and are 
consistent with physical observations of persistent muculent effluent.  This material build-up 
may act as a barrier to transport during decellularization and impede subsequent recellularization 





























Figure 3.6 – Residence Time Distributions 
 
Modeling of tracer pulse experiments using MatLab™ and COMSOL™ with two-
parameter flow models showed best fit with two ideal continuously stirred tank reactors in 
series with recycle (A).  The flow properties of the entire organ before (B) and after 
decellularization (C) were considered from a mass transport perspective.  Ideally mixed 
volume and recirculation parameters were both reduced after decellularization, suggesting 






3.2.3 Tissue Conditioning and Culture 
 
Cryopreservation was observed to reduce the overall size of the cannulated whole-organ ECM.  
This compression may have been caused by uniform freezing and the expansion of the 
surrounding cryoprotectant medium or by dehydration of matrix proteins during freezing.  The 
tissue was found to expand to typical volume following perfusion reconditioning (Figure 3.2).  
Disinfection with an aqueous solution of 0.1% (v/v) peracetic acid and 4% (v/v) ethanol slightly 
increased the opacity of the ECM. 
 
Phase contrast images of the ventricular lumen (Figure 3.7A,C) suggest preserved tissue 
microstructure as previously demonstrated with similar decellularization protocols (Ott, 
Matthiesen et al. 2008).  Corresponding fluorescent images showed widespread adhesion of 
seeded cells following 9 days of culture.  The clusters of observed cells suggest proliferation 
during culture.  High magnification images showed substantial cell spreading and multiple focal 
adhesions (Figure 3.7B,D).  Collocation of CFDA-SE signal with Hoescht and phalloidin 






Figure 3.7 – Staining and Imaging of Tissue Lumen 
Phase contrast images of the tissue microstructure are shown following decellularization, 
reconditioning and culture (A,C).  Corresponding fluorescent imaging (B,D) shows 
extensive cell attachment with DAPI (blue) and phalloidin (red) staining.  Cell morphology 
including focal adhesions indicates cell health and viability (D).  Colocalization (H, merge) 
of phalloidin (E, red), Hoescht (F, blue), and CFDA (G, green) with confocal imaging 







This work examined practical aspects of the production of tissue-engineered constructs from 
animal tissue.  These included the study of transport phenomena central to perfusion 
decellularization protocols.  Specifically, we investigated the dynamics of protein loss in 
decellularizing tissue and flow properties in perfusion decellularization. 
 
The importance of flow considerations in perfusion decellularization was highlighted in 
preliminary work by induced mechanical modifications such as perforation and clotting by 
heparin omission.  These conditions increased the decellularization time by a factor of 3 or more 
(data not shown).  Mechanical modification and processing is common in the isolation and 
decellularization of tissue (Lin, Chan et al. 2004; Mertsching, Walles et al. 2005; Brown, 
Lindberg et al. 2006) and resultant flow effects may be significant to process efficiency and 
completeness. 
 
In perfusion decellularization, model fitting suggests an increase in stagnant volume at 15 hours 
of SDS treatment.  This is believed to be caused by the accumulation of muculent cellular debris, 
such as chromatin and glycosylated proteins.  Stagnant regions have little  exchange of material 
with well-mixed volumes (Nauman 2004), and decrease the efficiency of transport processes as 
both a physical barrier and by reducing the magnitude of concentration gradients that drive 




Flow properties are not only important to the efficiency and completeness of a decellularization 
process, but also influence the detergent denaturation processes on extracellular matrix.  For 
example, the denaturing power of detergents such as SDS increases with concentration 
(Reynolds and Tanford 1970).  High local concentrations of SDS may result in increased 
denaturation of extracellular matrix proteins which have been shown vulnerable to detergents 
(Gratzer, Harrison et al. 2006).  Flow patterns determine the distribution and severity of hotspots 
in the tissue with respect to detergent damage. 
 
Variation in total removed protein from 130 to 200 mg protein per gram of heart wet weight, and 
required decellularization time from 6 to 24 hr may reflect variations in residual clotted blood, 
particularly microclots following heparin flushing.  The presence of microclots enhanced by the 
absence of systemic heparinization, may present transport challenges that would be encountered 
in the development of bioartificial hearts from human donors. 
 
Bulk protein effluent curves (Figure 3.5) indicated that the protein loss occurred primarily in the 
initial hours of decellularization before approaching zero.  This profile agrees with the 
hypothesis that the organ comprises solubilizable and nonsolubilizable pools of protein with 
respect to decellularization.   In an ideal protocol, the former would comprise all of the tissue’s 
cellular material, while the latter would comprise all of the desirable matrix materials to remain 
after decellularization. 
 
In this work decellularized ECM was preserved for up to 1 yr before being used successfully for 
cell attachment and culture.  Such “stops” are advantageous for tissue engineering processes 
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which operate on a commercial scale to help match output to need (Kemp 2006).  A strategy of 
modular processing was adopted to decrease the potential of cross-contamination of surfactant or 
pathogens and increase equipment specialization with the long-term goal of increasing 
throughput, and lowering cost. 
 
Reconditioning was considered a distinct and important process step. It has been shown that 
residual detergent can persist in tissue even after extensive washing (Cebotari, Tudorache et al.).  
The goal of the mild detergent treatment is to remove SDS from tissue (Ott, Matthiesen et al. 
2008) via the formation of mixed detergent micelles that serve as an SDS carrier with a higher 
affinity than water alone  (Ossipow, Laemmli et al. 1993).   However, this treatment may deposit 
secondary detergent on the tissue proteins.  In this way, the reconditioning steps are considered 
as substitutions of progressively less harmful surfactants.  Following the secondary detergent 
wash, a protein solution was passed through the tissue.  Surfactants can then partition onto the 
proteins in solution, combining the transport efficiencies of perfusion with the detergent binding 
sites of proteins for surfactant removal.  The protein wash could also comprise autologous 
plasma or recombinant proteins.  Media protein components (FBS) were used to displace 
adsorbed proteins from the previous wash, and the tissue was finally equilibrated against media.  
Together, this treatment was designed to help ensure the removal of residual detergent, DNA, 
and cryoprotectant; balance the ECM with respect to pH and osmolarity; and deposit media 
growth factors and nutrients prior to cell seeding 
 
Sterility and throughput are critical for decellularization processes for routine application.  
Towards this goal, disposable/autoclavable cannulae and culture environments were designed.  
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The disposable tubing cannulae may be cut as desired, interfaced with standard chromatography 
fittings, and kept with the tissue during storage.  The entire liquid circuit is autoclavable prior to 
use, comprising the glassware (settling vessel, and reactor) and optionally disposable tubing.  
The bubble-free aeration used prevents bubble-associated cell death (Handa-Corrigan and Emery 
1989; Chisti 2000) and the production of foam that could block the material flow in the 
bioreactor or tissue lumen. 
 
The properties of decellularized tissue have made it a material of choice for engineering complex 
tissues including heart (Ott, Matthiesen et al. 2008) and liver (Uygun, Soto-Gutierrez et al. 
2009).  Although tissue-derived ECM is a popular material for tissue engineering applications, 
processing is poorly understood and often requires empirical optimization for a given application 
(Hudson, Liu et al. 2004; Woods and Gratzer 2005; Ott, Matthiesen et al. 2008; Liu, Bharadwaj 
et al. 2009).  An improved understanding of decellularization in the context of cell seeding and 
culture can aid in the development of protocols for a given application and interpretation of the 





Chapter 4 – Derivative Materials 
 
 




Decellularization of subsections of tissues using washes was investigated as an alternative to 
whole-organ perfusion to facilitate parallel production and throughput while simultaneously 
reducing tissue use and animal sacrifice in screening experiments.  Decellularization in a rack of 
centrifuge tubes to produce ECM for study eliminates the need for cannulation and the perfusion 
decellularization apparatus.  Removing the requirement of cannulation also simplifies the study 
of decellularization of a broader range of tissues.   
 
Decellularization of tissue sections without whole-organ perfusion may have clinical potential in 
additional to experimental utility.  Applications may include decellularization of damaged tissues 
and the production of tissue patches or other surgical materials.  It is conceivable that the 
decellularization of diffuse tissues, partial tissues, or tissue sections will be more clinically 
relevant than the decellularization of whole organs, which may require whole-organ tissue 











   
 
Figure 4.1 – Cardiac Tissue Decellularized in a Semi-Batch Process 
 
The feasibility of semi-batch tissue decellularization was also investigated.  In this scheme, 
sequential washes are used to remove cellular debris without perfusion through the 
vasculature.  This allows more tissue sections to be processed and eliminates the need for 
surgical cannulation.  However, transport efficiency may be decreased.  A preliminary 





4.1.2 Materials and Methods 
 
All animal-related procedures were approved by the University of Waterloo Animal Care 
Committee.  Adult Sprague Dawley rats (475-585g; n = 3) were group housed 4 per cage at 
constant air temperature (20-21°C) and humidity (approx. 50%) in a 12:12-hr reverse light:dark 
cycle facility.  Rats had free access to water and standard 22/5 Rodent Diet (W) lab chow 
(Harlan, Indianapolis IN).  On the day of the experiment, body mass was recorded and rats were 
anesthetized with sodium pentobarbital injection (60 mg/kg intraperitoneally; Vetoquinol N-A, 
Lavaltrie, QC, Canada).  The animals were systemically injected with 2500 U of heparin 
(Bioshop, Burlington ON, Canada) in phosphate buffered saline (PBS) as an anticoagulant.  
Tissues were removed, and placed in chilled PBS with 100 μg/mL ampicillin and 50 μg/mL 
kanamycin. 
 
Tissues were rinsed thoroughly in PBS with ampicillin and kanamycin, and divided into sections 
of tissue.  Hearts were divided into left and right atria, and dorsal / ventral left and right 
ventricular masses.  Kidney, Liver and Lung were left intact at this stage. 
 
Tissues were treated with combinations of decellularization approaches to broadly screen for 
effective techniques.  Elements included 1 hr treatment in a sonication bath, a freeze-thaw cycle 
to -38°C, 4% (v/v) Triton X-100™ detergent (octyl phenol ethoxylate), 1% (w/v) sodium 
dodecyl sulfate, and 0.1% (w/v) EDTA.  Detergents were dissolved in PBS with ampicillin and 
kanamycin.  Tissue samples were placed in centrifuge tubes with detergent solutions, and 
solutions were changed every 2 hr during the day in a laminar flow hood.  Decellularizing tissues 
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were kept under agitation at 4°C.  The assignment of tissues and protocols is outlined in Table 
4.1.  After 24 hr, tissue sections that were large enough to cause gross decellularization gradients 
were dissected into smaller pieces and the decellularization protocol was repeated. 
 
Tissues were rinsed twice for 12 hr with deionized water with ampicillin, kanamycin and 100 
μg/mL streptomycin then rinsed with DMEM.  Tissues were then rinsed in NeuroCult® NS-A 
medium supplemented with 20 ng/mL recombinant human EGF, 10 ng/mL recombinant human 
bFGF, and 2 μg/mL heparin.  NS medium was conditioned with equal parts medium that had 
been exposed to NS cell culture for two days and contained cell-secreted cytokines. 
 
Tissue samples were placed in a six-well plate with additional conditioned media and each well 
was seeded with 2x105 neural stem (NS) cells, chosen for their sensitivity and availability, to 





Sample Anatomy Protocol Summary 
A Left Atrium Sonication, then 4% Triton 
B Right Atrium Freeze, then 4% Triton 
C Left Atrium 4% Triton 
D Right Atrium 4% Triton, 0.1% EDTA 
E Dorsal Right Ventricle 1% SDS, then 1%Triton 
F Ventral Right Ventricle 1% SDS, 1% Triton 
G Dorsal Left Ventricle Freeze, Sonication, then 1% SDS, 1% Triton 
H Ventral Left Ventricle 0.5% SDS 
I-1 Left Atrium 1% SDS 
I-2 Right Atrium 1% SDS 
I-3 Dorsal Left Ventricle 1% SDS 
I-4 Ventral Left Ventricle 1% SDS 
I-5 Dorsal Right Ventricle 1% SDS 
I-6 Ventral Right Ventricle 1% SDS 
J Dorsal Left Ventricle Sonication, then 1% SDS 
K Ventral Left Ventricle Freeze, then 1% SDS 
L Dorsal Right Ventricle 1.5% SDS 
M Ventral Right Ventricle 1% SDS, 0.1% EDTA 
N-1 Kidney 1% SDS 
N-2 Kidney        " 
N-3 Liver        "  
N-4 Liver        " 
N-5 Lung        "  
N-6 Lung        "  
Table 4.1 – Batch Tissue Decellularization Experimental Summary 
Tissue and common decellularization protocol combinations were tested and studied for 
suitability in semi-batch decellularization.   SDS and Triton X-100™ are both used 
frequently in decellularization literature, but have different strengths.  SDS is a strong 





After 2 days, the cells were imaged and assigned a qualitative score based on the number of 
apparent cells and their apparent health.  Guidelines used are shown in Figure 4.2.  
Epifluorescent and brightfield imaging was performed on an inverted fluorescent microscope 
(Axiovert 200; Carl Zeiss MicroImaging GmbH, Berlin, Germany) with a monochrome high 
resolution CCD camera (XCD-SX910/X710; Sony Corporation, Tokyo, Japan). 
 
 
Figure 4.2 – Cell Score Guideline Images 
 
Qualitative guideline images of unhealthy phenotype with high cell number (A), healthy 
cell phenotype with high cell number (B), unhealthy cell phenotype with low number (C), 






Processed tissue fragments obtained a uniform translucent appearance shown in Figure 4.3.  SDS 
treatment tended to yield a paler ECM than milder treatments.  The size of the tissue fragment 
was also associated with the observed completeness of decellularization, demonstrating the 
importance of transport limitations in the tissue.  Lung was observed to more quickly achieve 
translucency.  This may be due to lower cell density or open structure. 
 
 
Figure 4.3 – Semi-Batch Decellularized Tissues 
 
Decellularized tissue sections (clockwise from top left) of kidney, liver, lung, ventral section 
of right ventricle, dorsal section of right ventricle, and right atrium.  Codes correspond to 
the protocols outlined in Table 3.1.  Increased translucency of SDS detergent treatment in 






Microscope imaging showed the preservation of vascular structure following decellularization as 
shown in Figure 4.4 after relatively harsh SDS decellularization.  Strategies to address focus and 





Figure 4.4 – Capillary Structure in Decellularized Lung 
 
Semi-batch SDS decellularized lung was imaged on an inverted brightfield microscope with 
phase contrast.  Four depths of field are shown (A-D) to present the complex three 
dimensional structure of the tissue.  Scale bars indicate 100 μm.  These results show the 







Results of the NS cytotoxicity assay are summarized in Table 4.2.  One plate of four became 
contaminated during the NS cytotoxicity assay, and these samples were given a score of ‘x’.  
Stronger detergents such as SDS and detergent blends with SDS tended to produce less cytotoxic 
material, suggesting cell debris may have a greater impact on local cytotoxicity than detergent in 
the short term.  However, duplicate samples of SDS-treated kidney showed poor repeatability. 
 
Imaging also suggestived of incomplete decellularization in tissues treated with semi-batch 
detergent treatments.  DAPI staining revealed residual DNA resembling distended nuclei even in 
tissues treated with SDS (Figure 4.5A), which has been demonstrated to remove nuclear material 
in whole organ perfusion decellularization (Ott, Matthiesen et al. 2008).  Tissues with associated 
fat, particularly kidney and heart, tended to from lipid droplets over time (Figure 4.5B) after 
detergent solutions were replaced with media.   
 
Figure 4.5 – Indications of Incomplete Decellularization 
 
DAPI staining revealed residual DNA as diffuse chromatin and distended nuclei under 
epifluorescent imaging (A).  Brightfield images showed the formation of lipid droplets 
(arrows), particularly in tissues with associated fat such as kidney and heart (B).  These 
were found develop after media changes, suggesting incomplete removal of solubilized 





Sample Tissue Protocol Summary Amount Health Score 
A Heart Sonication, then 4% Triton 3 3 9 
B Heart Freeze, then 4% Triton 3 3 9 
C Heart 4% Triton 3 2 6 
D Heart 4% Triton, 0.1% EDTA 4 2 8 
E Heart 1% SDS, then 1%Triton 5 3 15 
F Heart 1% SDS, 1% Triton 6 4 24 
G Heart Freeze, Sonication, then 1% SDS, 1% Triton 4 2 8 
H Heart 0.5% SDS 4 3 12 
I-1 Heart 1% SDS x x x 
I-2 Heart 1% SDS x x x 
I-3 Heart 1% SDS x x x 
I-4 Heart 1% SDS x x x 
I-5 Heart 1% SDS x x x 
I-6 Heart 1% SDS x x x 
J Heart Sonication, then 1% SDS 6 1 6 
K Heart Freeze, then 1% SDS 4 1 4 
L Heart 1.5% SDS 4 3 12 
M Heart 1% SDS, 0.1% EDTA 3 3 9 
N-1 Kidney 1% SDS 9 9 81 
N-2 Kidney " 4 4 16 
N-3 Liver " 3 4 12 
N-4 Liver " 6 5 30 
N-5 Lung " 4 2 8 
N-6 Lung " 2 2 4 
Table 4.2 – Cytotoxicity Assay Results Summary 
Decellularized tissues and the protocols tested are shown.  The qualitative abundance of 
cells was scored between 1 and 10 using three randomly selected fields of view.  A score of 
qualitative cell health was also assigned.  The overall cytotoxicity score was the product of 
these two values.  A score of ‘x’ indicates the sample was destroyed due to a contaminated 







The initial screening experiments demonstrated the potential of semi-batch decellularization for 
small tissue fragments.  The preserved microstructure and partial removal of cellular material is 
valuable towards the production of near-native engineered materials from animal tissue. 
 
Short term cytotoxicity assays showed reduced cytotoxicity with stronger detergents and 
detergent mixtures containing SDS.  This suggests that the dominant cytotoxic effects observed 
in this experiment were due cell debris, apoptotic cell signaling molecules, or partially 
solubilized membrane-containing detergent, which are more likely to be removed by stronger 
detergents. 
 
Although it may be desirable to produce decellularized tissues without cannulating and 
decellularizing an entire organ, the transport challenges of removing perfusion must be 
considered during protocol development.  When large tissues were dissected to produce smaller 
samples before further processing, a gradient was observed with increasing translucency to the 
exterior of the tissue.  Greater control over the size distribution of tissue fragments will be useful 
to produce repeatably decellularized materials and develop protocols that completely 
decellularize tissue without overly damaging the most easily-decellularized regions. 
 
Transport issues may be particularly important for DNA removal due to its large and highly 
charged structures.  In the protocols tested, residual distended nuclei and chromatin were 
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observed coating the ECM following DAPI staining, demonstrating the need for nuclease 
treatment for complete decellularization. 
 
Additional residual material included droplet-forming lipids in the tissue.  This is believed to be 
the result of detergent treatment and incomplete removal of detergent-lipid complexes.  This is 
supported by the exaggerated formation in fattier materials such as the kidney and emphasizes 
the importance of upstream processing and tissue preparation.  Complete removal of fatty tissues 
or undesired transport-limiting structures such as the renal capsule may be as important to 
consistent processing as tissue geometry.  Unfortunately, this re-emphasis on upstream handling 
and surgery diminishes some of the principle advantages of this approach, such as ease of scale-
up and simplified tissue preparation.  The utility of this experiment lies mostly in revealing the 
broad processes of decellularization under varied conditions while minimizing the need to collect 
animal tissue. 
 




The ECM materials being developed must support cell attachment, growth, and proliferation for 
effective cell therapy.  Although the cytotoxicity assay presented in Section 3.1 gives an indirect 
measure of the quality of the extracellular matrix in biological terms, robust cell seeding and 




4.2.2 Decellularized and Seeded Slices 
 
Tissue slices were investigated to create a consistent geometry.  Regular thickness and distance 
to the free solution is desirable to facilitate consistent decellularization processes, and to 
facilitate uniform imaging between samples.  In addition, tissue slices were investigated to create 
an even surface for cell seeding and entrapment. 
 
Tissues from a Sprague Dawley Rat prepared as described in 3.1.2 were mounted in a microtome 
(Leica Mikrosysteme GmbH, Vienna, Austria) with stainless steel razor blades (Feather Safety 
Razor Co. Ltd., Osaka, Japan).  However, the thickness of the tissues produced was inconsistent.  
Firm tissues such as kidney were resistant to the blade and deformed readily.  Frozen tissues 
could be sliced to as thin as 0.5 mm, however only a small amount of material could be produced 
before thawing resulted in irregular or wasted materials.  Maintaining tissue temperature without 
using a cryomicrotome also proved impractical, and over-chilled samples were prone to cracking 
and splintering. 
 
An alternative method to support the tissue and control even slicing was the use of a tissue slicer 
matrix shown in Figure 4.6.  The tissue slicer facilitated the production of samples at 0.5 or 1.0 
mm thickness, with more consistency and in greater amount that with the microtome.  
 
Heart, Kidney, and Liver tissues were isolated as described previously and sliced to a thickness 
of 1.0 mm in a coronal slicer matrix.  Two candidate protocols were tested in the cell seeding and 
cytotoxicity experiments.  The first comprised 4% (v/v) Triton X-100™ with 0.1% (w/v) EDTA, 
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and the second comprised 1% (v/v) Triton X-100™ and 0.5% (w/v) sodium deoxycholate.  
These detergents were selected for being well-supported in literature (Samouillan, Lamure et al. 
2000; Spina, Ortolani et al. 2003). Longer protocols, thinner tissue sections, and addition of 
benzonase treatment were adopted to remove cell debris shown in Section 3.1.  Both protocols 
used two-day semi-batch detergent decellularization with agitation at 4°C, and liquid changes 
every 2 hours and overnight.  This was followed by incubation with 25 U/mL Benzonase™ 
nuclease (EMD Chemicals Ltd., Gibbstown, NJ) in a buffer containing 50 mM Tris-HCl pH 8, 
20 mM NaCl, and 2 mM MgCl2.  Decellularization solutions and nuclease buffer also contained 
antibiotic antimycotic solution (Sigma-Aldrich Canada Ltd., Oakville, ON, Canada) with 10,000 
U/mL penicillin G, 10 mg/mL streptomycin sulfate and 25 μg/ml amphotericin B.   
 
 
Figure 4.6 – 0.5mm Coronal Rat Heart Tissue Slicer Matrix (Zivic Instruments™) 
 
The tissue slicer matrix supports the tissue during cutting to reduce warping and produce 
more consistent results.    Coronal matrices cut the tissue perpendicular to the long axis of 
heart.  Razor blades are slid with downward pressure into the matrix.  Slices are then 
collected from between the blades.  1 mm slices were found to be more repeatable than 0.5 
mm slices.   
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Tissues were rinsed twice in DMEM for 1 hr each, then rinsed for 1 hr in endothelial cell 
medium comprising MCDB-131 (Invitrogen Canada Inc., Burlington, ON, Canada) 
supplemented with an endothelial growth medium-2 Sinqlequot™ (Lonza, Walkersville, MD), 2 
mM L-Glutamine, and 10% (v/v) fetal bovine serum (Invitrogen Canada Inc., Burlington, ON, 
Canada).   Slicing and decellularization was found to maintain the tissue microstructure as shown 





Figure 4.7 – Microstructure of Decellularized Kidney Slide 
 
The cross-section of the renal cortex is shown following mechanical processing and 
decellularization.  The microstructure of the renal tubules are preserved, similar to the 








The surface of each tissue slice was overlaid with 1x104 human umbilical vein endothelial cells 
(HUVECs) that had been cultured in the endothelial cell medium on tissue-treated 75 cm2 
polystyrene flasks (BD, Mississauga, ON, Canada) coated with gelatin from bovine skin, type B 
(Sigma-Aldrich Canada Ltd., Oakville, ON, Canada).  200 μL of endothelial cell suspension was 
gently applied to each tissue slice before incubation and in six-well plates in a total volume of 2 
mL for 2 hours.  Additional media was then gently added to each well. 
 
After two days of culture, the wells were imaged to assess the degree of cell attachment and 
survival.  In wells with tissue decellularized with 4% (w/v) Triton X-100™ and 0.1% (w/v) 
EDTA, cell phenotype was observed to be healthier and with greater attachment further from the 
tissue, suggesting potential cytotoxicity of the matrix.  The effect was observed to a lesser degree 
in the tissues treated with 1% (v/v) Triton X-100™ and 0.5% (w/v) sodium deoxycholate.  The 
quantity of cells at the bottom of the wells was also suggestive of poor attachment particularly 

























Figure 4.8 – Cultured Tissue Slices 
 
1 mm tissue sections prepared in the slicer matrix were overlaid with 1x104 HUVECs and 
cultured for two days in a six-well plate.  The sections were reversed and imaged for cell 
proliferation and health.  The left wells contain kidney tissue, the middle wells contain 






Samples were incubated with 1 μM CFDA-SE for 1 hour at 37°C to image metabolically active 
cells in the tissue.  Kidney tissue was found to present the most viable adherent cells (Figure 
4.9).  The porous structure of the cross-sectioned tissue may have contributed to improved cell 
entrapment, and may also have facilitated transport for more complete decellularization and 
reduced cytotoxicity. 
 
CFDA-SE is converted by cytoplasmic enzymes to 6-carboxyfluorescein succinimidyl ester, 
which fluoresces and binds to free amine groups.  The high level of background signal may have 
been caused by binding of the fluorophore to the proteins of the matrix itself after being secreted 
by labeled cells.  This is supported by the observed increase in background signal over time.  







Figure 4.9 – CFDA-SE Stained Cultured Kidney Slice  
 
A 1 mm section of kidney prepared in a tissue slicer matrix and cultured with HUVECs for 
two days.  The sample was incubated with 1 μM CFDA-SE for 1 hour, rinsed, and mounted 
on a glass slide.  Elongated morphology suggests good cell attachment, and fluorescence 
indicates metabolic activity.  Background fluorescence may be caused by fluorophore 




4.2.3 Gelatin-Coated ECM 
 
A kidney isolated from a Sprague Dawley rat was cannulated with PEEK tubing in the renal vein 
and stored at -80°C was thawed after 1 mo and mounted on the perfusion decellularization 
apparatus described in Chapter 2.  The kidney was decellularized with 1% SDS in PBS with 
antibiotic antimycotic at 2 mL / min for 24 hr.  The tissue was then disinfected by flushing with 
an aqueous solution of 0.1% (v/v) peracetic acid and 4% (v/v) ethanol (Rosario, Reilly et al. 
2008; Liu, Bharadwaj et al. 2009) and stored in PBS at 4°C.  Perfusion decellularization and 
sterilization were selected to produce the most completely decellularized and uniform ECM 
available when testing the effect of matrix coatings, with stored material used to reduce the 
amount of animal sacrifice. 
 
The decellularized and disinfected kidney was then cut into 1mm thick sections (n = 6) using the 
tissue slicer matrix as described above.   The tissue samples were rinsed twice with DMEM for 1 
hr, then once with the endothelial cell media described above.  Kidney sections were placed in a 
six well plate, and half of the samples were coated with a solution of 1 mg/mL gelatin from 
bovine skin, type B, with excess gelatin removed by aspiration.  Endothelial cell medium was 
then added to each well and allowed to equilibrate in an incubator for 1 hr. 
 
Mouse blood outgrowth endothelial cells (mBOECs) were cultured in endothelial cell medium 
on gelatin-coated plates, trypsinized, and seeded at 2x105 cells per tissue sample.  After 24 hr of 
culture the samples were transferred to a new well plate with fresh medium.  After six additional 
days of culture, kidney slices were labeled with 1 μM CFDA-SE, incubated for 1 hr, turned over 
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to image the seeded surface and imaged (Figure 4.10).  The gelatin-coated tissue appears to have 
improved cell attachment and morphology.  However, depth-of-field and focus problems 
interfered with quantification.  Additionally, background fluorescence obscured the majority of 
cells. 
 
This experiment suggests that ECM coatings can improve seeding efficiency and viability in 





Figure 4.10 – Gelatin-Coated Seeded Tissue Sections 
 
Gelatin-coated kidney ECM (A) appears to have improved cell attachment and 
morphology over non-coated kidney ECM (B). Limited focus and background fluorescence 









Derivatives of decellularized matrices were also investigated for cell culture.  In particular, gels 
and coatings were developed to facilitate imaging of cells during cytotoxicity bioassays.  This 
work was aimed towards providing quantitative in vitro evaluation of decellularization protocols 
from a biocompatibility perspective. 
Homogenous materials have additional advantages of improved replication for given 
decellularized tissue sample.  Imaging several well plates coated with an identical material was 
anticipated to be much more consistent than imaging different regions of a complex three-
dimensional tissue.  The amount of material required for a two-dimensional culture was 
anticipated to be less than culturing complete decellularized tissues. This would increase 
throughput and reduce tissue requirements for decellularization process optimization. 
ECM coatings and gels are also an active area of research for therapeutic applications, in 
addition to roles as cell culture tool and for cell-matrix studies (Lin, Chan et al. 2004; Stern, 
Myers et al. 2009; Zhang, He et al. 2009).  These experiments also facilitated the investigation of 





4.3.2 Acetic Acid Extraction 
 
The kidney of a Sprague Dawley rat was removed, cannulated, stored at -80°C for 6 wk, and 
decellularized with 1% SDS in PBS with antibiotic antimycotic at 2 mL / min for 24 hr.  The 
fatty tissue and renal capsule were removed with a scalpel before the tissue was placed into a 
tissue press and passed twice through a 0.5 mm screen (Figure 4.11).  Fibrous material in the 
screen was then discarded.  The resulting slurry was placed in PBS with antibiotic antimycotic, 
agitated, allowed to settle and the supernatant was discarded.  The decellularized kidney slurry 
was then homogenized with a pulsed sonication tip of a W-225 ultrasonic processor (Heat 
Systems Ultrasonic, Inc.) at 40% power for 5 min.  The resulting suspension was centrifuged at 
855 RCF for 10 min and the supernatant was discarded (Figure 4.12). 
 
 
Figure 4.11 – Tissue Press 
 
A tissue press was used to mechanically process soft tissues into slurry following trimming 
of excess fat and connective tissue.  Fibrous material was removed from the 0.5 mm screen 




A solution of 0.4% (v/v) acetic acid was added to the solids and agitated until partially dissolved. 
Half of the resulting suspension was then passed through a 40 μm filter.  The solution was used 
to coat 16 wells of a 24 well plate, with quadruplicate conditions each of filtered, unfiltered, 2x 
diluted, and undiluted solution at 250 μL material per well.  The plate was exposed to UV 
sterilization for 30 minutes and remaining solution was aspirated.  The wells were then rinsed 5 




Figure 4.12 – Sonicated and Centrifuged ECM Suspension 
 
Decellularized ECM slurry was treated in a pulsed ultrasonic processor in PBS with 
antibiotic antimycotic and centrifuged at 855 RCF for 10 min in a centrifuge tube.  The 




Canine blood outgrowth endothelial cells (cBOECs) were cultured in endothelial cell medium on 
gelatin-coated plates and trypsinized as described previously.  Each well was then seeded with 
1x105 cells with gelatin-coated plastic as a control (Figure 4.13).  After 5 days of culture on the 
adsorbed ECM coating (Figure 4.14), the cells elongated and formed capillary-like networks 
similar to those observed following endothelial cell culture on Matrigel™ (Kubota, Kleinman et 
al. 1988), a commercially available basement membrane-derived gel (BD, Mississauga, ON, 
Canada).  This suggests that the coating retained important matrix components such as collagen, 
laminin, and growth factors.  However, it is unknown how closely the coating reflects the 
original decellularized tissue slurry. 
 
After 6 days of the culture, the adsorbed coating formed a floccular precipitate, similar to that 
described when ECM components are mixed in solution at physiological ratios and conditions 
(Kleinman, McGarvey et al. 1983; Woodley, Rao et al. 1983).  A more stable surface is required 
for long-term cytotoxicity imaging studies.  This might be achieved by additional collagen cross-
linking, blending the coating with stabilizers, using ultracentrifugation and lyophilization to 
purify more readily soluble components (Stern, Myers et al. 2009; Zhang, He et al. 2009), or 











Figure 4.13 – cBOECs on a Gelatin-Coated Surface at 5 days 
 
1x105 cBOECs were cultured on a 25cm2 tissue-treated polystyrene T-flask with a gelatin 
coating for 5 days.  These cells have an attached and slightly elongated morphology.  Scale 


















Figure 4.14 – cBOECs on an ECM-Adsorbed Surface at 5 days 
 
1x105 cBOECs were cultured on a 25cm2  tissue-treated polystyrene with an adsorbed 
ECM coating prepared from an acetic acid extraction of sonicated ECM.  Cells appeared 




4.3.3 ECM-Derived Gels 
 
Perfusion decellularized kidney slurry was prepared as described above with SDS vascular 
perfusion followed by tissue pressing.  The material was then rinsed with PBS containing 
antibiotic antimycotic solution, sonicated, and centrifuged as described.  The solids were 
resuspended in 2M urea and agitated at 4°C for 3 days.  The solution was centrifuged and 2 mL 
of supernatant was then dialyzed in 250 mL PBS with 5% (v/v) chloroform to sterilize the 
solution in 6000-8000 MWC dialysis tubing (Kleinman, McGarvey et al. 1986).  Dialysis was 
performed on ice in a fume hood with 3 buffer changes.  The buffer was then replaced with 
DMEM with 3 additional buffer changes.  The solution was then brought to 0.02N acetic acid 
using a stock solution of 0.35N acid. 
The solution was combined with rat tail collagen to produce stocks of 0%, 10%, and 50% (v/v) 
ECM extract in collagen.  A neutralizing solution was prepared with 100mM HEPES adjusted to 
pH 7.3 in 2x PBS (Wozniak and Keely 2005).   cBOECs were cultured as described above, 
trypsinized, resuspended, and combined with chilled equal parts of the collagen solutions and 
neutralizing solution to a final concentration of 1x105 cells per mL.  Solutions were mixed with 
chilled pipettes in a biological safety cabinet, and 5 μL volumes were cast in glass imaging 
chambers treated with aminopropyl trimethoxysilane (APTS).  The discs were allowed to cast for 
30 min in an incubator at 37°C, and the imaging chambers were then filled with media. 
 
After 10 days of culture, the discs were stained with DAPI and imaged (Figure 4.15) under 
brightfield and fluorescent imaging.  Figure 4.16 presents the same samples under higher 
magnification to resolve individual nuclei.  Areas largely absent of cells in Figure 4.15 B,D, and 
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F, appear to correspond to areas of thin gel deposition, pointing to incomplete mixing of 
materials or uneven flow during casting.  These may be caused by premature solidification and 
contribute to the technical difficulties of producing large amounts small gel carriers.  However 
gel production facilitated the use of chloroform dialysis to ensure sterility, presenting an 
advantage over other materials produced in this chapter. 
 
The rat tail collagen gel presented the most regular appearance in both the gel morphology and 
the distribution of cells.  The 50% ECM gel has a more granular appearance than the other 
samples, suggesting a different organization structure which may be related to the formation of 





Figure 4.15 – Cultured ECM/Collagen Discs Overview 
 
ECM gel was prepared from a 2M urea extract of ultrasonicated decellularized ECM, and 
then dialyzed against buffer and basal medium.  Brightfield (left column) and fluorescent 
DAPI images (right column) are shown for mixtures of ECM and collagen gel with 0% 
(A,B), 10% (C,D), and 50% (E,F) ECM gel content.  Gels were cast at 1x105 cells per mL 




Figure 4.16 – Cultured ECM/Collagen Discs 20x Magnification 
 
The gel discs from Figure 4.16 imaged at a higher magnification.  Individual nuclei can be 
observed, showing high confluence.  Cell densities appear higher at lower ECM 
concentrations suggesting residual cytotoxicity from ECM gel processing.  Large regions 
without cells may have resulted from incomplete mixing of the cell suspension and gel 






In this chapter, decellularization of tissue sections was investigated as an alternative to whole-
organ perfusion.  Developing techniques to decellularize using washes and eliminating 
cannulation was aimed to increase throughput, scalability, and allow the production of a wider 
variety of materials for diverse applications. 
 
Decellularization of tissue sections without whole-organ perfusion may have clinical potential in 
addition to experimental utility.  Applications may include decellularization of damaged tissues 
and the production of tissue patches or other surgical materials.  It is conceivable that the 
decellularization of diffuse tissues, partial tissues, or tissue sections will be more clinically 
relevant than the decellularization of whole organs, which may require whole-organ tissue 
engineering or replacement. 
 
Cytotoxicity assays using both sensitive and robust cell lines were used to evaluate combinations 
of tissue and decellularization protocols.  Stronger detergents and detergent blends may have 
produced less cytotoxic material, suggesting incomplete decellularization in the protocols tested.  
However, more repeatable bioassays are required. Imaging also indicated incomplete semi-batch 
decellularization.  DAPI staining showed residual nuclei and chromatin, and lipid droplets were 
observed to form in the ECM. 
 
Approaches were tested to produce more uniform tissue sections, achieve more complete 
decellularization, and develop robust seeding protocols.  Other materials including coatings and 
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gels were tested.  Coatings were found to induce morphological changes associated with 
capillary formation, implying bioactivity of the ECM and its derivatives. 
 
Residual cytotoxicity from incomplete decellularization or reconditioning may be caused by 
transport limitations, particularly in the absence of vascular perfusion.  Reducing the size of the 
ECM fragments was observed to facilitate decellularization during the production of gels and 
coatings.  Using progressively smaller ECM also increases the surface area for cell attachment, 
reduces material use, and provides alternatives for handling and culture.  This will be further 





Chapter 5 – Micronized ECM Carriers 
 




The heavily processed decellularized matrix described in Chapter 3 was also investigated as a 
product, in addition to its previously discussed role as an intermediate to study large 
decellularized tissues.  Potential applications of micronized decellularized material include 
wound modulation (Pietramaggiori, Scherer et al. 2008), surgical filler (Sclafani, Romo et al. 
2000), and for soft tissue engineering (Yoo and Lim 2009).  The focus of this work is the 
development of micronized ECM towards the support of gene-modified cell therapy by 
promoting survival of transplanted adherent cells in vivo. 
 
Micronized matrix as a final product also has production advantages over tissue section and 
whole organ tissue engineering.  Increased surface area facilitates decellularization mass 
transport processes, provides more area for seeding, and simplifies mounting and imaging.  The 
increased surface area also facilitates higher density culture and reduces animal tissue use. 
 
5.1.2 Materials and Methods 
 
Canine blood outgrowth endothelial cells (cBOECs) were a generous gift from Dr. David 
Lillicrap, Queen’s University.  Cells were cultured in MCDB-131 (Invitrogen Canada Inc., 
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Burlington, ON, Canada) supplemented with an Endothelial Growth Medium-2 Sinqlequot™ kit 
(Lonza, Walkersville, MD), 2 mM L-Glutamine, and 10% (v/v) fetal bovine serum (Invitrogen 
Canada Inc., Burlington, ON, Canada) .  Cells were cultured in tissue-treated 75 cm2 polystyrene 
flasks (BD, Mississauga, ON, Canada) coated with rat tail collagen, type I (BD, Mississauga, 
ON, Canada) in a controlled atmosphere at 37°C and 5% CO2.  Cells were passaged at 90% 
confluency with 2.5 g/L trypsin with 0.38 g/L EDTA (Invitrogen Canada Inc., Burlington, ON, 
Canada) every 3-4 days. 
 
All animal-related procedures were approved by the University of Waterloo Animal Care 
Committee.  Adult Sprague Dawley rats were group housed 4 per cage at constant air 
temperature (20-21°C) and humidity (approx. 50%) in a 12:12-hr reverse light:dark cycle 
facility.  Rats had free access to water and standard 22/5 Rodent Diet (W) lab chow (Harlan, 
Indianapolis IN).  On the day of the experiment, body mass was recorded and rats were 
anesthetized with sodium pentobarbital injection (60 mg/kg intraperitoneally; Vetoquinol N-A, 
Lavaltrie, QC, Canada).  Tissues were removed, and placed in chilled PBS with 100 μg/mL 
ampicillin and 50 μg/mL kanamycin. 
 
A Sprague Dawley kidney was harvested and cannulated with PEEK tubing in the renal vein, and  
perfusion decellularized using the apparatus described in Chapter 2 with  1% Triton X-100™, 
0.5% sodium deoxycholate, with 100 U/mL penicillin and 100 μg/mL streptomycin in PBS at 2 
mL / min for 24 hr.  The decellularized kidney was then stored for 2 months at -80°C in PBS.  
The tissue was thawed and passed through a tissue press as described in Chapter 3, rinsed with 
PBS with antibiotic antimycotic solution (Sigma-Aldrich Canada Ltd., Oakville, ON, Canada) 
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with 10,000 U/mL penicillin G, 10 mg/mL streptomycin sulfate and 25 μg/mL amphotericin B, 
and disinfected with 0.1% (v/v) peracetic acid and 4% (v/v) ethanol in deionized water for 3 min.  
The ECM was then rinsed with sterile PBS, equilibrated with DMEM for 2 days, and 
equilibrated with cBOEC medium described above for 1 day.  The ECM was seeded with 2x106 
cBOECs with 3.5 mL of medium in a 10 mL falcon tube.  The tube was allowed to equilibrate 
with a loosened cap in an incubator overnight, before being transferred to a six well plate for 
culture.  To image metabolically active cells, carrier samples were incubated for 10 minutes with 
DMEM containing 1 μM CFDA-SE.  Samples were then rinsed with PBS in a microcentrifuge 




Figure 5.1 – Mounted Tissue Carrier Sample 
 
The production of small ECM carriers facilitated wet mounting.  Flattened carriers 
reduced depth of field issues and also created a narrower column of excited tissue during 




In a second protocol, an uncannulated kidney stored at -80°C in PBS without detergent treatment 
was tested.  The tissue was thawed, removed of fatty tissue and the renal capsule, passed twice 
through a tissue press with fibrous tissue discarded.  The material was rinsed in PBS with 
antibiotic antimycotic solution then ground in a mortar and pestle to further reduce carrier size.  
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The material was then transferred to a centrifuge tube and agitated in a decellularization solution 
of 1% Triton X-100™, 0.5% sodium deoxycholate, with 100 U/mL penicillin and 100 μg/mL 
streptomycin in PBS at 4°C, with liquid changes every 24 hr for 8 days.  The material was then 
rinsed in nuclease buffer comprising 50 mM Tris-HCl pH 8, 20 mM NaCl, and 2 mM MgCl2 for 
24 hr, before incubation with 6.25 U/mL Benzonase™ nuclease (EMD Chemicals Ltd., 
Gibbstown, NJ) in fresh buffer for 24 hr.  The carriers were rinsed in sterile PBS with antibiotic 
antimycotic and disinfected with 0.1% (v/v) peracetic acid and 4% (v/v) ethanol in deionized 
water for 3 min.  The disinfected carriers were rinsed with sterile PBS, equilibrated with DMEM 
for 2 days, then equilibrated with cBOEC medium for 1 day.  The decellularized carriers were 
seeded with 1x106 cBOECs in 3.5 mL of medium, incubated overnight in a 5% CO2 controlled 




Figure 5.2 – Crushed Matrix Carriers in Medium 
 
Coated imaging chambers made from coverslips allowed culture and in situ imaging of 




Cultured tissue samples from the second protocol were incubated with 2 μg/mL Hoescht 33342 
(ABD Bioquest, Sunnyvale, CA) for 30 min in a microcentrifuge tube.  The carriers were rinsed 
3 times with media, then once with PBS.  The sample was fixed in 4% paraformaldehyde for 15 
min, permeabilized in 0.5% (v/v) Triton-X100™ solution for 20 min, blocked with 5% BSA for 
20 min, then rinsed 3 times in PBS for 5 min each, stained with AlexaFluor® 546 phalloidin 
(Invitrogen Canada Inc., Burlington, ON, Canada), washed 3 times for 5 min each in PBS, and 
placed on a coverslip.  Epifluorescent imaging was performed on an inverted fluorescent 
microscope (Axiovert 200; Carl Zeiss MicroImaging GmbH, Berlin, Germany) with a 
monochrome high resolution CCD camera (XCD-SX910/X710; Sony Corporation, Tokyo, 
Japan), followed by sequential fluorescent imaging on a confocal microscope (FV1000; Olympus 




Small matrix carriers were found to simplify imaging by facilitating wet mounting.  This reduced 
the depth-of-field and focus issues that had made larger tissue carriers difficult to image without 
dissection, and sub-sampling.  This improved imaging facilitated viability staining, as shown in 
Figure 5.3, pictured after 12 days of culture. 
 
Brightfield images in the left column highlight the complex structure and texture of the 
extracellular matrix.  This structure prevents brightfield imaging of cells with the exception of 
some cells on the outer edges of the tissues such as in Figure 4.3A.  Although mounting reduces 
the problems of imaging in three dimensional cultured tissues, CFDA-SE staining remained 
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difficult to image due to high background signal.  Fluorophore may be secreted by the cells and 
bind to matrix proteins.  Proteases secreted by the cells may also activate the fluorophore prior to 
binding.  Image processing comprised Background subtraction with a 50 pixel rolling ball 
algorithm in the ImageJ software package (National Institutes of Health, Bethesda, MD).  The 
low number of imaged cells suggests poor attachment and growth; however, many of these cells 







Figure 5.3 – Mounted Carriers with Viability Staining 
 
Crushed kidney tissue was detergent decellularized, seeded with 1x106 cBOECs, and 
cultured for 12 days. Wet mounted tissue pieces facilitated brightfield (left column) and 
epifluorescent (right column) imaging of the samples.  Incubation with 1 μM CFDA-SE 
revealed metabolically active cells with attached morphology. Image processing of the 
fluorescent images allowed for background subtraction (right column), however weaker 




In the subsequent experiment, decellularization was performed after mechanical processing.  
Rather than using these small tissue pieces to study the properties of larger decellularized 
materials, this experiment was in context of crushed carriers as a separate product.  The increase 
in surface area and reduction of ECM thickness facilitates improved mass transfer, and wash 
times were increased to reflect indications of residual cytotoxic material from semi-batch 
decellularization described in Chapter 2.  After 12 days of cBOEC culture, nuclear staining and 
cytoskeletal staining was performed to identify attached cells (Figure 5.4) and indicate cell 
attachment, health, phenotype, and the formation of larger structures on the extracellular matrix 




Figure 5.4 – Mounted Carriers with Nuclear and Cytoskeletal Staining 
 
Brightfield imaging did not indicate widespread cell attachment (left column), however 
nuclear staining (blue) showed areas of dense cell coverage (right column).  Cytoskeletal 
staining (red) showed cell spreading in all areas. In well stained regions (D) a continuous 
layer of endothelial cells is visible.  Cells were also observed to form   closed-loops 
resembling capillary-like structures (arrows).  Scale bars indicate 50 μm. 
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The advantages of mechanically processed fresh tissue in decellularized tissue engineering 
applications can be increased further by reducing the size of tissue fragments closer in size to 
commercially available microcarriers.  Smaller tissue carriers increase surface area for mass 
transport processing steps, seeding, and reduced tissue use.  Microcarrier-sized tissue fragments 
simplify tissue culture strategies by providing established microcarrier seeding and culture 
protocols as a basis for process development.  By facilitating spinner culture, micronized ECM 
also facilitates scale-up and three dimensional cultures and may help provide therapeutically 
significant cell numbers. 
 
5.2.2 Materials and Methods 
 
Wistar rats were housed as described previously for Sprague-Dawley rats and were sacrificed by 
carbon dioxide asphyxiation for an unrelated project.  Hearts, lungs, livers, and kidneys were 
collected to reduce animal sacrifice and waste.  Tissues were stored in PBS with antibiotic 
antimycotic and frozen at -80°C for up to 4 months before use. 
 
Tissues were mechanically pressed as described above, with trimming of fatty and connective 
tissues, and fibrous material discarded from the press.  Slurries were rinsed three times in PBS 
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and samples were sonicated and taken for histological analysis.  The remaining slurries were 
then decellularized with washes of 1% Triton X-100™, 0.5% sodium deoxycholate, changed 
twice a day for 5 days,  and rinsed nuclease buffer.  Samples were taken again for histological 
investigation, and the remaining material was incubated with 25 U/mL of benzonase at 37°C. 
These materials were then rinsed three more times with PBS.  All solutions contained 1x 
antibiotic antimycotic.  The slurry was disinfected with peracetic acid as described previously.  
The tissue was then sonicated with the tip of a W-225 ultrasonic processor (Heat Systems 
Ultrasonic, Inc., Farmingdale, NY) pulsed at 40% power for 2 min.  The solids were then 
allowed to settle for 4 hours, and rinsed in sterile PBS.   
 
Samples of settled ECM solids were sonicated without nuclease treatment, and pipetted on to 
positively charged glass slides (Superfrost™; Fisher Scientific Company; Ottawa, ON, Canada), 
and desiccated for two days to ensure adherence of the decellularized matrix to the slides.  The 
slides were then loaded into a rack and rehydrated for 2 min in deionized water.  The slides were 
then transferred to a working solution of hematoxylin for 5 min to stain nuclei and other 
basophilic structures, rinsed under running tap water for 5 min, transferred to a working solution 
of eosin for 5 min to stain collagen and cytoplasm, rinsed with running tap water for 2 min, and 
mounted with aqueous mounting medium under a coverslip. 
 
3 mL of micronized heart carriers were conditioned in fetal bovine serum, allowed to settle for 4 
hours, rinsed twice in complete endothelial cell medium, settled and seeded with 1 mL of 
medium containing 1x106 cBOECs.  Seeded carriers were incubated for 4 hr with gentle 
agitation every hour.  The seeded carriers and unattached cells were loaded into a small spinner 
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flask at 120 rpm with 80 mL of medium and incubated.  Samples from the spinner culture were 




Sonicated carriers have the advantage of reduced size.  Individual fragments can be brought to 
sizes comparable to conventional microcarriers on the order of 100 μm (Yang, Rossi et al. 2007).  
This allows the adaption of common microcarrier culture techniques and scalable high-density 
culture.  The decreased size also creates more surface area for cell seeding per gram of 
decellularized tissue, reducing the matrix required for a given target cell load and decreasing the 
need for fresh tissue.  However, sonication was observed to reduce of portion matrix fragments 
to debris of insufficient size to support multiple cells.  This material is not recovered during 
washes with mild centrifugation, while ultracentrifugation produces pellets that are impractical to 
dissociate by trituration.  The resulting loss of ECM to debris, and uneven reduction of size 
between tissue fragments must be addressed to efficiently produce uniform carriers. 
 
Sonication also produces fibrous materials when used with some tissues (Figure 5.5), particularly 
liver and lung, which were observed to form aggregates during handling and rinsing.  
Additionally, fibrous carriers may result in warping during culture and send undesirable signals 
to the cells via mechanotransduction (Ma, Liu et al. 2008).    Finally, excessive sonication may 






Figure 5.5 – H&E Staining of Decellularized Tissues 
 
Hematoxylin and eosin stains of sonicated tissue before (left column) and after (right 
column) detergent decellularization.  Kidney, Liver, and Lung are shown in the top, middle 
and bottom rows, respectively.  In H&E staining, nucleic acids stain blue, revealing diffuse 
chromatin in the sonicated tissues.  This is reduced during detergent decellularization, 
however condensed nuclei remain entangled in the matrix as observed in Chapter 3.  Pink 
stains indicate alkaline eosinophilic stuctures, such as proteins.  These persist in the thick 
regions of tissue (D,F) after decellularization, and may correspond to undesired residual 
cellular components or valuable matrix components that have not been stripped.  The 




Unlike other tissues tested, particularly liver and lung, sonicated cardiac tissue forms rounded 
carriers desirable for handling and spinner culture.  Samples of heart microcarriers from a 
spinner flask were sampled after 1 week of culture, fixed, permeabilized, stained and mounted 
(Figure 5.6).  Near-confluent cell coverage on the ECM carriers, demonstrates effective cell 
seeding, and may indicate proliferation in spinner culture. 
 
Samples of heart microcarriers in media removed from spinner culture were also loaded in 
APTS-treated gelatin-coated glass imaging chambers after 1 week of culture.  Chambers were 
positioned on an inverted fluorescent microscope (Axiovert 200; Carl Zeiss MicroImaging 
GmbH, Berlin, Germany) with a monochrome high resolution CCD camera (XCD-SX910/X710; 
Sony Corporation, Tokyo, Japan), with controlled temperature and atmosphere.  Time-course 
images of carriers were constructed using a custom robotic stage and image processing software 
(Figure 5.7).  Although some cell movement was observed in the brightfield movies, no cell 
egress was observed.  Additionally, dead cells and debris were observed to settle from the 
solution, with only several viable cells observed on the gelatin surface.  The slow settling time of 
the debris suggests simple media changes may be sufficient for debris removal in long-term 
spinner cultures.  The carrier itself was observed to drift over time which may have prevented 




Figure 5.6 – Cultured Sonicated Heart Carrier Staining 
 
Samples of heart microcarriers from a spinner flask were sampled after 1 week of culture, 
fixed, permeabilized, stained and wet mounted.  Sonication may have damaged collagen 
fibrils on the edge of the carriers, resulting in the frayed edge morphology shown in the 
brightfield images (A,B; 100 μm scale) after paraformaldehyde fixing.  These edges were 
also observed to broadly autofluoresce as shown in the ultraviolet channel (C-F; 100 μm 
scale), obscuring cytoskeletal staining (results not shown).  Nuclear staining indicated a 
near-confluent layer of endothelial cells, indicating effective cell seeding and low 




Figure 5.7 – Cultured Sonicated Heart Carrier Timecourse Imaging 
 
Sonicated heart ECM microcarriers were seeded with 1x106 cBOECs in 1 mL of medium, 
and cultured for 1 week in a spinner flask at 120 rpm.  Samples were loaded in gelatin-
coated imaging chambers and imaged at controlled temperature and atmosphere for 24 
hrs.  Timecourse images revealed limited cell movement and no cell egress.  Over time, 
dead cells and debris were observed to settle from the solution.  Media changes may be 
required to remove debris from the system.  Motion of the microcarrier may have 




Samples of carriers cultured for 9 days were rinsed in sterile PBS and cast in rat tail collagen, 
type I (BD, Mississauga, ON, Canada) combined with a neutralizing solution of 100mM HEPES 
adjusted to pH 7.3 in 2x PBS (Wozniak and Keely 2005), and handled with chilled pipettes and 
solutions.  The gels were cast in glass imaging chambers, allowed to set in a 37°C incubator for 
30 min, and overlaid with fresh media.  Time course images were prepared on an inverted 
microscope with controlled temperature and atmosphere (Figure 5.8).  Cell division and egress 
into surrounding collagen were observed throughout the timecourse images. 
 
At 72 hours following gel casting, carriers were imaged at lower magnification to resolve depth-
of-field and study the cell egress pattern (Figure 5.9).  The images showed nearly all of the 
particles to carry viable dividing cells following extended spinner culture.  These results and the 
divisions observed on the carrier during timecourse imaging support the study of ECM 





Figure 5.8 – Cultured Sonicated Heart Carrier, Collagen Cast, Timecourse Imaging 
 
Sonicated heart ECM microcarriers were seeded with 1x106 cBOECs in 1 mL of medium, 
and cultured for 9 days in a spinner flask at 120 rpm.  Samples were rinsed in sterile PBS 
and cast in type I rat tail collagen with a neutralizing solution in glass imaging chambers.  
Solutions and materials were chilled to 4°C.  Imaging chamber gels were allowed to set at 
37°C under controlled atmosphere for 30 min before adding fresh media. High-resolutions 
time course imaging revealed cell movement and cell division on the ECM surface. Egress 





Figure 5.9 – Cultured Sonicated Heart Carrier, Collagen Cast, 72 Hour Cell Egress 
 
Sonicated heart ECM microcarriers were seeded with cBOECs, and cultured for 9 days in 
a spinner flask.  Samples were rinsed in sterile PBS and cast in type I rat tail collagen with 
in glass imaging chambers.  Gels were allowed to set at 37°C under controlled atmosphere 
for 30 min before adding fresh media.  After 72 hours of 3D gel culture most particles had 
released dividing cells, demonstrating the ability of spinner cultured ECM microcarriers to 









Mechanical processing of fresh collagen induces shear that can separate collagen fibers (Gilbert, 
Stolz et al. 2005).  This may be reflected in the frayed morphology observed in sonicated tissue 
carriers.  Snap freezing and tissue cracking was investigated to break collagen fibrils more 
evenly.  This was anticipated to prevent the fibrous morphology observed in some tissues and 
reduce microcarrier entanglement and aggregation during handling and culture. 
 
Pulverization by tissue cracking was also anticipated to reduce the formation of matrix debris 
lost in the supernatant following sonication, by mechanically favoring the destruction of larger 
particles.  This would result in more uniform carriers and reduce wasted ECM. 
 
5.3.2 Materials and Methods 
 
Tissues from Wistar rats stored as described previously were thawed, removed of fatty tissue, cut 
into sections of approximately 0.5 mL volume, and were placed in microcentrifuge tubes on ice.  
The tubes were then snap frozen in liquid nitrogen and stored at -80°C until needed.  A stainless 
steel mortar and pestle type cryopulverizer was custom-machined (Figure 5.10) to process large 
amounts of tissue.  The pulverizer was carefully submerged in liquid nitrogen in a polystyrene 
foam container with heavy gloves.  Snap frozen tissues were loaded into the pulverizer and the 
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piston was struck with a heavy hammer approximately 5 – 10 times until the tissue formed a fine 
powder.  This was then emptied into a centrifuge tube with PBS, allowed to settle and washed 




Figure 5.10 – Custom High Capacity Cryopulverizer 
 
A high capacity cryopulverizer was milled from stainless steel.  The mortar and piston 
surfaces were cooled and the mortar was semi-submerged in liquid nitrogen in a 
polystyrene foam container.  Small tissue pieces were loaded into microcentrifuge tubes, 
and submerged in liquid nitrogen until frozen.  Tissues were loaded in the mortar, and the 
piston was struck several times with a hammer.  The mortar was then removed from the 






The micronized tissue was rinsed in a decellularization solution of 1% Triton X-100™ (Sigma-
Aldrich Canada Ltd., Oakville, ON, Canada) and 0.5% sodium deoxycholate (Bioshop Canada, 
Inc., Burling, ON, Canada) changed twice per day for 7 days, rinsed with nuclease buffer, then 
incubated with 6.25 U/mL units of Benzonase™ (Sigma-Aldrich Canada Ltd., Oakville, ON, 
Canada) in buffer for 24hr.  The tissue was then rinsed 3 times with PBS.  All solutions 
contained 1x antibiotic antimycotic solution (Sigma-Aldrich Canada Ltd., Oakville, ON, Canada) 
and kept at 4°C.  Carriers were disinfected with 0.1% (v/v) peracetic acid (Sigma-Aldrich 
Canada Ltd., Oakville, ON, Canada) and 4% ethanol for 5 min, rinsed 3 times with sterile PBS, 
aliquoted in centrifuge tubes and stored at -80°C for up to 1 month (Figure 5.10).  Microcarrier 
aliquots were then thawed at 4°C to reduce the bubble nucleation in the matrix and improve 
settling.  Microcarriers were conditioned in fetal bovine serum (Invitrogen Canada Inc., 
Burlington, ON, Canada) for 2 days, and rinsed with endothelial cell medium. 
 
Trypsinized endothelial cells were added to microcarriers in medium, gently agitated every hour 
and allowed to settle in an incubator with a loosened cap.  Samples of the supernatant were taken 
to determine the proportion of unattached cells.  In one experiment, CFDA-SE labeled cells were 
used to study cell entrapment and seeding.  Seeded carriers were then loaded into glass imaging 
chambers, or into a spinner flask and cultured in an incubator at 37°C and 5% CO2.  To test cell 
seeding kinetics, 3.5x105 cells in 1 mL of media were seeded on 0.5 mL settled volume of lung 





Figure 5.11 – Cryopulverized Lung Carrier Spinner Culture 
 
Aliquots of micronized ECM were aliquoted in PBS and stored at -80°C (A).  After 
thawing, ECM samples were reconditioned with FBS and complete medium washes.  Cells 
were then added to tissue microcarriers and allowed to attach in a centrifuge tube with a 
loosen cap in a controlled 5% CO2 atmosphere at 37°C (B), with gentle agitation every 
hour.  Once seeded, the tissue microcarriers were loaded in a spinner flask (C, D).  




5.3.3 Results  
 
The cell seeding kinetics test showed indicated 16% entrapment at 1 hour, and 94% cell 
entrapment at 2 hours.  These cells were not found in the gently triturated sampled supernatant, 
and were considered bound to the matrix or otherwise associated with the carriers during 20 
minutes of settling time.  Microcarriers seeded with CFDA-SE labeled cells after 4 hr seeding are 
shown in Figure 5.12.  The small size of these carriers and brightly labeled cells facilitate 
imaging without flattening the three dimensional structure by mounting under a glass slide.  The 
roughness of the tissue may contribute to cell entrapment.  Loading was also observed to be 
more even than the cell attachment observed in larger crushed carriers seeded without agitation. 
 
Sonicated heart carriers were also observed to support cell survival after 10 days of culture as 
demonstrated by cell egress in Figure 5.13.  Sampled carriers were loaded on a glass imaging 
chamber coated with type I rat tail collagen, and imaged after 16 hours. 
 
Reduced carrier size observed when compared to other carrier production approaches increases 
attachment area and facilitates mass transport during decellularization, disinfection, and 
reconditioning processes.  Egress was also observed without gel casting and this may be caused 
by using a collagen coating rather than the gelatin coatings used previously.  Alternatively, the 









Figure 5.12 – Lung Carriers at 4 hr Seeding 
 
Microcarriers are shown seeded with CFDA-SE labeled cells after 4 hr seeding.  Brightfield 
images are shown in the left column, with corresponding epifluorescent images at two 
depths-of-field in the middle and right columns.  The complex surface of the microcarriers 
may facilitate cell entrapment and improve cell seeding efficiency.  Even cell attachment is 





Figure 5.13 – Heart Microcarrier 16 hr Egress 
 
Sonicated heart ECM microcarriers were cultured for 10 days.  Sampled carriers were 
loaded on a glass imaging chamber coated with type I rat tail collagen, and imaged after 16 
hours.  Egress was observed without gel casting and may be facilitated by the collagen 
coating or the decreased microcarrier size relative to cell bridge strength.  Streams of cells 
show high cell density on carriers and maintenance of proliferative potential on ECM in 








A primary goal of this work is to develop a carrier to facilitate cell survival in gene-modified 
BOEC transplanted for the treatment of hemophilia (Matsui, Shibata et al. 2007).  This can only 
be directly tested with animal experiments including survival surgery.  However, it is desirable to 
develop an assay that simulates the in vivo environment, particularly with respect to death of 
transplanted BOECs (Matsui, Shibata et al. 2007; Milbauer, Enenstein et al. 2009), to minimize 
animal use.  This will facilitate meaningful testing of the carriers developed in the protocols 
above, and their role in cell survival. 
 
A confluent layer of HeLa cells was selected to produce a competitive culture environment as an 
intermediate step towards animal experiments.  HeLa cells divide rapidly to quickly cover 
exposed culture surface.  This was designed to recapitulate the assumed absence of acellular 
surface at the transplant site of the host animal.  Additionally, the metabolic activity of the HeLa 
cells was desired to further challenge transplanted cells with and without carrier.  Imaging of 







Preliminary studies of CFDA-SE labeling of cBOECs showed loss of signal intensity during 
culture.  In Figure 5.14, CFDA-SE labeled cells were loaded into a collagen-coated glass 
imaging chamber as described above.  After 3 days, the fluorescent cell signal became nearly 
unidentifiable at low magnifications.  These imaging issues were resolved by the availability of 
gene-modified GFP-expressing mBOECs. 
 
 
Figure 5.14 – Loss of Fluorescent Signal in CFDA-SE labeled cBOECs 
 
CFDA-SE labeled cells were loaded into collagen-coated glass imaging chamber.  
Chambers were imaged in brightfield (left) and fluorescent channels (right), at 0 hr (top) 
and 3 days (bottom).  After 3 days, fluorescent cell signal became nearly unidentifiable at 
low magnifications (D).  Low magnification is desired to image the three dimensional 
structure of the carriers in situ while minimizing depth-of-field issues.  Additionally, 
background fluorescence in the media increased due to release of the fluorophore from the 
BOECs.  This may then bind and concentrate protein carriers, further complicating the 
study of carriers in a survival assay. Scale bar indicates 100 μm.    
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5.4.2 Materials and Methods 
 
APTS-treated glass imaging chambers were loaded with 4x105 HeLa cells, or left empty as 
controls (Figure 5.14).  After 2 days, the HeLa cells formed a confluent layer.  Media was 
replaced with the endothelial medium described above.  1x105 GFP-expressing mBOECs were 
seeded in each well or loaded onto 25 μL of settled cryopulverized kidney carriers prepared as 
described above.  After 2 hr of seeding, the carriers were transferred to the glass chambers and 
imaged as described above.  Every 2 days, half of the medium was removed from the chambers 




Figure 5.15 – Experimental HeLa Layers 
 
Imaging chambers were loaded with 4x105 HeLa cells, or left empty as controls (A).  A 
confluent layer of HeLa cells was formed after 2 days (B).  1x105 GFP-expressing mBOECs 
were seeded in each well or loaded onto 25 μL settled volume of cryopulverized kidney for 
2 hr prior to imaging.  Half media changes and imaging were performed every 2 days.  
Overgrowth of HeLa cells at 16 days is shown (C).  Scale bar indicates 100 μm.  
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5.4.3 Results  
 
Seeded mBOECs were found to adhere and adopt a spread morphology within 24 hours, 
proliferating and becoming confluent within a week as shown Figure 5.16.  Seeded carriers 
showed good attachment and egress onto the surface of the imaging chamber. 
 
While BOECs were able to attach in the presence of the HeLa cells at 24 hr, they exhibited an 
elongated phenotype.  This may indicate that individual cells found small areas between HeLa 
cells on which to attach, but these are irregular and widely spaced.  By 9 days, GFP cell debris 
and widespread cell death is apparent.  This may be caused by the movement and division of the 
pre-existing cell layer, further disrupting proper attachment and resulting in programmed cell 
death (Frisch and Ruoslahti 1997).  By 16 days, only small debris remained. 
 
Seeded tissue carriers cultured on the HeLa layer were found to maintain attachment as long as 
16 days.  However, imaging was obscured by the increasingly thick HeLa cell layer.  The HeLa 
layer caused reduced proliferation in the first days of culture, and prevented significant BOEC 
egress.  By 1 week the HeLa layer began to cause cell death.  
 
These results suggest that ECM microcarriers can promote transplant cell survival in a confluent 
and competitive environment by providing a stable attachment surface.  Growth factors in the 
matrix deposited during FBS conditioning may also have contributed to cell survival, suggesting 





Figure 5.16 – GFP mBOECs on HeLa Layer with and without Micronized Tissue Carriers 
 
GFP mBOECs are shown in the left column.  These cells attached with spread morphology 
within 24 hours before becoming confluent.  Seeded carriers shown in the second column 
exhibited good attachment and egress of proliferative cells.  In the third column, BOECs 
seeded on the HeLa layer attached at 24 hr, but exhibited a distorted phenotype.  By 9 
days, GFP cell debris and widespread cell death is apparent.  By 16 days, only small debris 
remained.  In the forth column, seeded tissue carriers on the HeLa layer are shown to 
maintain attachment as long as 16 days.  However, imaging was increasingly obscured by 
the thick HeLa cell layer shown in (C).  The HeLa layer caused reduced proliferation in the 
first days of culture, and prevented significant BOEC egress.  By 1 week the HeLa layer 





Methods were developed to produce and evaluate micronized ECM.  This work was focused 
toward developing a carrier to support gene-modified adherent cell therapy by providing a 
biological surface for attachment and support for implanted cells. 
 
Tissue micronization had additional production advantages by resulting in a more homogeneous 
material prior to decellularization, facilitating process optimization, simplifying handling, and 
allowing the adaptation of established microcarrier protocols.  Increased surface area and 
reduced tissue thickness also facilitate decellularization transport processes and provide more 
attachment sites for seeded cells.  Improved transport may also reduce hypoxia in microcarriers 
following implant. 
 
A tissue press was used first to produce small ECM fragments in Section 4.1.  These were 
studied for culture and decellularization.  For the second generation carriers, ultrasonication was 
applied to reduce the size of the fragments in Section 4.2.  These smaller fragments further 
facilitated imaging, handling, and seeding, and were cultured in spinner flasks.  However, this 
approach destroys a portion of the ECM by shredding to debris, and tends to produce fibrous 
carriers from liver and lung. 
 
In the third generation of microcarriers, we employed snap-freezing and cryopulverization of 
tissue pieces.  This approach was anticipated to reduce the formation of debris by preferentially 
applying force to larger particles, reducing waste and improving uniformity.  Tissues were 
cracked by snap freezing and crushing prior to decellularization, further increasing surface area 
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and reducing bulk transport distances during decellularization.  Resulting microcarriers behaved 
more closely to commercial microcarriers, further facilitating scalable, high-density spinner 
culture. 
 
Imaging assays were primarily used to evaluate seeding efficiency, cell survival, and 
proliferation.  Viability stains demonstrated cell metabolic activity, and cytoskeletal staining 
showed cell morphology on the ECM surface.  Time course imaging showed cell migration and 
proliferation on the carriers.  Collagen gel casting and coating egress assays demonstrated 
retention of proliferative and migratory cells during long-term spinner culture. 
 
An in vitro assay was developed to produce a competitive environment and test the ability of the 
ECM microcarriers to support implanted cells.  GFP-expressing BOECs were overlaid on 
confluent layers of HeLa cells with and without microcarrier support.  The experiment ended 
after 16 days, when the HeLa layer had overgrown and interfered with imaging.  Cells on the 
microcarrier demonstrated an attached morphology for the duration of the experiment.  Cells 
without microcarrier support were able to attach, however this attachment appeared stretched and 
distorted.  Widespread cell death was observed within days for those without carriers, and at the 
end of the experiment only fluorescent debris remained.  The debris was timecourse imaged to 
confirm Brownian motion.  The results  suggest that short term engraftment of implanted cells is 
possible, but ultimately unstable and agrees with reports of high losses of BOECs within days of 
injection (Milbauer, Enenstein et al. 2009).  These results also demonstrate that ECM 
microcarriers can support cell survival, however, in vivo experiments are ultimately needed to 
test therapeutic potential. 
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Chapter 6 – Conclusions and Recommendations 
 
6.1 Tissue Decellularization 
 
Whole-organ perfusion decellularization was investigated from a process engineering and mass 
transport perspective.  An emphasis was placed on process staging and production “stops”.  
Perfusion decellularization employs the transport advantages of the native vasculature, which 
was preserved during decellularization with harsh detergents.  The microvasculature reduces the 
distance between material in the tissue mass and the detergent solution.  However, in the absence 
of systematic heparinization, variations of 6 to 24 hrs were observed in decellularizing hearts.  
This variation may be caused by microclots and resulting poor microcirculation.  Since 
systematic heparinization is may not be possible for human tissue and excessive detergent 
treatment may be undesirable, decellularization protocols may require process analysis to 
determine completeness of decellularization.  However, many decellularization protocols simply 
prescribe durations of detergent treatment. 
 
Studying the flow properties of the decellularizing heart showed a reduction in volume and 
mixing over time.  Additionally, muculent effluent was observed at late decellularization.  This 
suggests muculent material accumulation in the vasculature such as chromatin or mucins that act 
as a barrier to transport in late decellularization.  Whole-organ perfusion decellularization 
protocols with alternating DNAse incubation and detergent perfusion may be valuable to ensure 
completeness in decellularization. 
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Tissue piece decellularization showed poor mass transport efficiency in the absence of vascular 
perfusion.  This was improved by reducing tissue size and the development cryopulverized ECM 
microcarriers from diverse source tissues.  Cryostorage of tissues and microcarrier aliquots was 
used throughout, with storage considered an essential step for commercial or therapeutic 
applications. 
 
6.2 Extracellular Matrix to Support BOEC Delivery 
 
BOECs were found to adopt an elongated phenotype when cultured on ECM and ECM derived 
gels, in contract to the cobblestone morphology observed when cultured on tissue-culture treated 
plastic or gelatin-coated surfaces.  The formation of capillary-like structures was also observed 
on both ECM and ECM gels.  Cells cultured on ECM remained proliferative and divisions were 
observed on the ECM surface during time-course imaging.  Extensive cell egress was observed 
following loading of BOEC tissue constructs onto gelatin, collagen, or tissue-treated plastic 
surfaces.  SDS and Tri-Col approaches are well-supported in literature and both produced 
carriers capable of supporting BOECs in spinner culture and releasing proliferative cells 
following seeding and imaging.   
 
No single tissue emerged as ideal for all ECM derivatives.  Heart tissue produced carriers with 
desirable rounded morphology following sonication, while kidney produced small jagged 
fragments, and lung and liver produced filamentous material.  However, cryopulverization 
increased recovery and produced materials with rounded morphology for all tissues.  Liver tissue 
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was used primarily due to availability, but produced the smallest volume of ECM of the 
materials tested.  Lung was found to produce the greatest volume of ECM per volume of raw 
tissue, and was studied extensively.  For cryopulverized BOEC carriers kidney and lung may be 
the most appropriate candidates due to their abundance of endothelial structures, however all 
tissue microcarriers tested supported cell attachment, culture, and egress.  
 
6.3 Cell Survival Assays 
 
Initial testing of decellularized materials included a semi-quantitative evaluation of cytotoxicity 
by culturing cells in the presence of decellularized tissue.  This indirect testing strategy was 
chosen for being unaffected by imaging challenges in large tissues.  Subsequently, seeded tissue 
microcarriers were cast in collagen or overlaid onto tissue-treated surface.  Cell egress was 
studied, and migration and division was observed with time-course imaging.  Viability and 
cytoskeletal staining was used with cultured whole organ samples and carriers to investigate 
survival and morphology. 
 
Following the results of these experiments, cryopulverized decellularized tissue microcarriers 
were selected as a candidate platform for BOEC delivery.  Microcarriers have the advantages of 
being scalable in spinner culture, providing high surface area for attachment, and can be injected 
subcutaneously.  Although cells were shown to be proliferative and form capillary-like structures 




To determine if the ECM carriers improve BOEC survival in a competitive environment, seeded 
carriers and cells alone were cultured on a confluent layer of HeLa cells.  Cells alone were 
shown to attach with a highly elongated morphology with widespread death within 9 days of 
culture.  The carrier was found to promote cell survival until 16 days when HeLa overgrowth 
interfered with imaging.  The results of this assay demonstrate that ECM microcarriers can 
promote cell survival in co-culture with robust cells, and contribute to the selection of 
cryopulverized ECM microcarriers as the candidate platform for animal studies. 
 
6.4 Future Work 
 
The focus of the work presented here was to develop an ECM-based tissue engineering approach 
to support ex vivo gene-modified cell therapy.  Although a promising candidate has been 
developed, additional characterization is required.  Important considerations include improved 
process understanding of decellularizing particles through chemical digestion and analysis, as 
well as histology over time.  Growth curves and kinetics of cells on the microcarriers, as well as 
cell FVIII productivity in culture also may provide indications of microcarrier quality.  However, 
it remains unknown if ECM microcarriers can effectively support BOECs in vivo. 
Lung and kidney microcarriers have been selected for an animal study to determine effectiveness 
and differences between the two materials.  If the microcarriers demonstrate effectiveness in cell 
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